ذدà،±ل>‏ے إا‏ےےےةتثئےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےے`!ًخ]€ںڑˆ‹¯فضW¤®»ّCb±[َطفv0ًHœ‏xعيڑ[hUادخجخهج™9³»س6ضؤnc“ط²Iskڑ` &غj,fىح§bKص—¦ف’چط⃱¬„`A !b%ٹR©Tؤ‡ôر+E± --RبK}Tث®ك\6¦M“&لشYلج0sffg‏َ;×فïى?‚4„ؤ{ë’Qr 61¢¢(¤؛ً¥ôzؤ="B7ù3!آرSHپ‎=،b±ـ_AH…ô/!êi¸ںّ×#ب„tƒE)ٌ€œ[iءv7÷ّ€ى?ƒfےaVسMë"إ¢ےقزف‘ûî‍û¯Jقف5¢ï‌6 ِمaعwل饽c¾j7)طiآZُ*.طكcضھ»´‚½[c­zC)ط7ضھن‚}P^‍ھ éذذذP گP،إ¨.م ز|>ڑV§ن—•sت%uR}¨.B©µ(cْ1 ھ…²ْ¨Rئiz‚ŒXêأ1Eدا§€êPيYZ´¬¾ھ7€jJں’g g´Iُ†6،Eٌ8ژâ1=§ڈ’* : T_U-شà%<;‹ٌَ،؟ئCِè#VBْ·p±è·زi?آ|Uw dُ£…—¹ـ ‘ / †u£ZحUـ¹چ¶ikلh÷غ‡ژ fO&_9|¸o ïحن`6ùھَRzا ]¨âéT‰ضہVû.H+لZز»î^u÷غ`]ƒ‍C[لج+B>½هإµ%ْˆ Tï=™ى;ْ/mٍ{âٌژUè¶T¢ڈخ–†¯َiP Gط•‚و•آ~ْ¹u7‏ع>ث‏ك1ڈل7£Spغ`Sc#”a; ڈ$C|’وذI‏ہ>IKè$ïh>Ikè$Eإ'ظ:ة²Oز¶D’‹ڈپؤًH®ر^ر‎¬©££¹ùkx,;¥€¥%|–‍hہز>ث9`ظ>KZ XعآgéR–­ل³tjK{ّ,د‥#|–ï·6|#6†دزF–¦ًYZچ€¥ ئف&3`)ƒq·پ,e0€¥ ئفM±€¥ ئف؛xہRمnM"`)ƒq·عX–8î^–¼ک‎ّNaآ²قc¹£ثB ژz3‎‎™ى±\2{8¹=›ëث‘v”@qط‘oD5گnD«a؟ظ;s×…ک‎8n¼=÷؟فkj½uM‎ئzچ؛›{\o=£?jî¨ô_فƒZlوگJ3S3jضتhا­¥ح <ژ( îصر¤ُ‍وئ÷½}‡r‎}9i¯ 4£Uق~ٌZxشجT)¯OèYë=ج¼â ¯_èîé¾}‌¨s9y[d†qةZ?گ0َF‚¼‎N\ٍيûv،ب]zùC‹شفدFضعk–C‏ژک.ywْEب[rV8B<ج‎±2·÷wp÷wp÷wp÷wp÷wp÷wp÷wpاےأكء}ـ§ء}ـ§ء}ـ§ء}ـ§ء}ـ§ء}ـ§ء}ـ§ء}ـ§ء}ـ§ٌx}‎eڈ÷ïnً=b”u‘AZٌ ˆ•u°ضے‰PNG  IHDRµiٹےM`PLTE؟هے€جے@³ےïùےںے0¬ے ¦ےدىے`؟ےںظےكٍےpئےڈزے¯كےP¹ےےےے™ے^&4›tRNSےےےےےےےےےےےےےےےے%­™bbKGD•² , cmPPJCmp0712Hs¼)IDATx^ي]뢣¬ُ®µ×÷ع³’€&ˆîîخ|gتڈ™îV²ب=`ُْ¶OR ںnصّô­ھêi8ٌّêؤ=ےض-‎ُRحDو¶؛\›î“®÷vl‎ذ^¦£½~Qثآ0ـ0صو“°u³ط|¹Uھ·êvçـ‡؛‎¢–!×  ىi}ˆ¼‏âل.kïسذصّہّµد€حس ,Hpضîد£f—ٍ)ڑüزMuDœ=ں'6\–gغ؟ھj.دٌِ¼¶دzآںcَêپ `,اي‹Z …ژ8 ز£ئىu؛جًڑ×üêgَx>ٌ¸]عçهص€¯غ©°َ/j)B­–قد¤AC¸گ،طلC{}½†ِy}µ×ي9w¯îFjچA¸U}n_شd"،ِ^#P ©±ہ½¯ٹ@"ش^مَِêYw “Mگ”€u؟}Q‹سâë¨ُàXءپn ]ِ¬‍-ىF­§؟ ±B.ثE÷«ن‹Zµذà_!ـç„ُٹ¦}ژ"َH«ء؛»ن2ء ¹6W(´çَ”&غë±ـ‘{خµ(u@ئم¼¶q– لœ~~خ_(yoü-ہھّJزr°5mB+ه‹Zµ­)2WhؤI¨أںZي®~ـœàƒP$ع2V·kك°¸$X[زv,P!BCطœق[‎E-†آ`m¾®dL† /د€–mkةWNƒ±^Cَlط+-¾¾l`ف]~¬_شb¨YYdضAٍ‰°َM@ہ:¢تک§قٍ¨ïة€ &&_µپ ‌{®¬cƒ‏èw?َ†~g¨¤]–Vنْخوآ†‏fgج5}ـ=ُ=j@HجGٍضژl†§¯Aï_شb¸›oةآث,Lأ×أ•®ةر ¾طàيْ5c¸ع"AنdQhمsشKl¥ى¾¨ي،Vچ§°اsش=‘&b™gڑط‰ششبé&»’Xٌ¾ôپ…]£‏Hٌيد£V²”?}چ&uپسثِ؛َ¦e¨7ً طmسfr¨ُIU,]پ•W_`^½\ّ«jû¢[ڑع+FLN¥‰ شz0Q¤¶غ‚,I¶¢!جإءغ%ôIDAT%چï“On©ُآOXuفµ7 ئ‍3G€±7g0^"&ض‌âءٌ^7“ـتح¹bإب× wةK`1R؟¨‎5b†پü¯Zr-5é§D¢^فذ4رrه ظ#®QF Wق ظ¥ë8(.³رںŒalذےüwه²C0EAب‘ "*Hzان#ç€/›ع]©ؤ+²غ”9PŒ="ک¸…™ ك2`_ش~ئkش§`گ§‡°PcŒ،Œ6¾fµ!)v¬جOâ[”%ّ³L® ²¦ش×i2R¾¨‎ 5r› µڑ‰ث2 ضE:صألJچڑـ@چثKo}zriëء غ©5‏%ڈà‹عدPC¬‍P4¦rح„چ‌0َ‘™¨Qƒˆta•é6خN‌QO³Xےlى\گëj—_شbگل;-ظ—ب×$·€ہـqpDˆك:X’"’ي=و^&‰ز¦vٌ¯¯گاb¢p طrQnظپ‎‹?£Fآfڑ{ژˆzڑ„ش$¤à­ر¨¹[¢صگچ,:™ظع،o´Jب4ùAظ‌s1jDد©ëœY–Nفٍ©ّ؟ IVتّ8ُغQث„c2ë‹”qdـrâ>ém‰إعC‍EهپTبوغ^cٍ5 r‌0>H³ف] :،ص°:]ue†½9+*«ڈ،‚†_Cmڈع9ôIDAT´-lY^K(k;YSمAب”ë»Wأê j,XڑNâ‏B_Z´M-ق¨>M`;چْ»r¯ش;â‎bJâ‹7َZ©Li_>èWlâmqGرHˆKyئqشگ‌q¢ŒQ ‍fz™خ¶µŒî_°$fkXîزd¨‏€Qأ.إ÷¢f \ط‰¬bصض^دًZhaحطدN­{فhثP­ج7ٹ لخح†vU€³·ّ™dkئژح|ام!•‹%ة¶,طي/àjAچ>ذ¬ZDbق‹عز[{Y+ŒڑچاDY[5 N¥ھ–†€3غ.¨ڈ؛èںن‍Q}ôkMةإTـعکh ةH#8–مà$Y{?ë&هƒ››ر£ وkµ –ب[Q[Y°أ¸ …ڈ©1L£fo ·­™M`€ظ¸´}Sµأf­£=•“«وXچح¬,».*Rkآ½‚› ¨8،ï°,قٹڑ²±§e†پش0ج–Dحجm³د„¶„©fتµحzڈlم 4د&آ’a%$بM£j*g[ًRŒ ض^"ر×صQٹ&%¨‰–ذ‎چ"ص؟€ڑغ²e¤`X‡«M’Dzl[ذ¸*{mڑظtيعضسàپ[×Jى€ِvْ/’Wu7s2[ ¨¢¨ةzٍYô™ط¥¨صà.ëOک‘p·iنïGmمڈةDسغTR¨ƒ"؛Eآô©T—Vُ¦ژ{¥¹eشح~15¦ھdI6¾ڑڑJYة¬üKyي?‚;êLa¦c6ƒڑظ÷¢ µ\ˆ„ث©…ص°,ةش‘سكmùےk¼&l$ؤZ6€H؛xك±W5·K›üن*–؟ˆ¹Iuèغ‎µ5‘†€چةs\ِ¬Aچ-C¼Vآٍî‌'\‰™¥كخپF)أ¯„t;¥×¼4DI%—*›5¶GR+Pè£$y7êïض<|0•7 سèr”‹ذ=خW Pے¯Q›mjِ¯“¨9عc§ز²½ ؤخ;c®Jccژک JU1$ظ:Lژ½1…gçثQ‹% أ‏2 Iَ>ص4oىtà|”ث«ئسّ> izSg¾¬ oٌâ|ژ?L0à@}T!,L®S~ؤےWں،pû£ض{َ“شّ&ِٹî¼/é€؟fضل‏6^EY‎گlR4‡ئش<5Q>â+´ˆـnM‡-Oد[&‰ً ë1SSإ€°( ââ,¸حتdJه¼ِQشخاFtبل#¨yi(;j¨­:f_±·ٌ,Um2‌ڑى$‹Jازîفrش´9ûë¼v5ح¥ںگگ‹4$‰&ش”sGˆ^™|c¸G„ô—¯r،³‎™§„وک†¯ërbG£–ù¢–؟ژڑ){€ƒ9WôIDAT;”©رإطںAح{صxڑس‎Lqâءèبٌnأؤ¦D'ڑ¤ûœs€^ثّى‡aسœ¨OزQ÷گëہJم½ ½Fٍٍà™ڑKڈ%ءUGGôعھؤj/ا8£‰}âيnبي‹Jُ³کأü}فز‌×’Kتھ5#³~‌×Lxلثکص•_Eé_¢وآ»0إdؤ¾زm+»W ¹'%NMQOأخz+پ~•P‹‏ـض€ڑ‰÷$…€ژ„x9ھ؟ث™ںڑŒçِش¬ٹFّ–cüعWçbط†زھ>„ہï؟j´[؛» ٌ*أDة¥$^?€ڑI?¥ِ2ڑطْR›،لH«j³,خي_Sِپsƒ·؛ب÷.[رAüRيُŒù°ے@/e`Vضضˆ|R{ظظ f÷»'ک-^W®هBZ%چ~n¯¨¢مr“رƒ‏^N;G{à÷ُ¦غىûXِ‹CKôZ?³U¹²çَ&Hک ْjض‏‰:%†صVC3éZ**غ3ہC…®©«oت|^WإD\"k>>زMIA¹‍©³nٍgîWG/1è·D¹qئُہو”َO fë £œ{be›“ŒK}{M(GO ¦kژ™oٌ¤†‏خٍ%£ھ×§¯ ْ‎–ضùٌ†gج5bïء´ڈ fui¶$O™ôa‚ ¯طƒ+6kُ jZ¤³ک\¨f9™خح¾pômsèِ"µù¨3%éصU…ظٍm8!R¸÷ش‚‚ڈ،ô6إ»ض^±ïv%اzں<غ'”—ءNˆ¶زً÷bRص—6أ`™¥ثءFچçôڈfE™ Aُ[TK[ئ%|aه``ٍVV†ا(ں=Gk£هô9¢p—W»l§آ2jhF- 8\bP KSعگf•؛IDATُ„·ء¹ dxjهِ^غz¶(ٍه6LA"84'Bù0.gء÷£ bf‍’گ4.إ$زظ;F+Kھ;5 oف69لٹDzنT'zwآEاMع^¯ك،•^o è­ز‹طksüذعک/x5h³صآgm9Lüزˆ [ئ¾à2zSچ2eZٌâ¶¼?ع$ جd‏§P ¥wآك‰»dحچŒ£;VحA‹ndw}çW†¸×ذû(¥¥±ïƒk؛+g ًزرّسyA$•_f ¦‎¼¶[تŒœl¨b 9ك6qïدPَ„€دڑكm…أd  Dڑ!®©i€ùnF-ٍ>nس5ے j[R'أïmc…?Fو¼„tگôغ“z×>+§dûحAہë5ù·²jœ…K6I£ے!شvSéôزضد ¦h­Rإ?C­KG¯ئëچ ”ùع ¯ƒ§-êj£'m®¼–=غf‏§P“|cھ…/ژ1â'ùêéحM,¢:~†¢ô‰]5l5u‹|§­¥ء™²ë£G‏5ع¯ل7[è³ط0µه£-pؤ¶3Lm}¸6J•¢Fآ«ژç—ة ھL–6rهں<^sھmE-†غ\¯÷ê2 فمjےبخصtسWھe¤ژçIwً¸l€ثOجAغ-«ژ·³u@ùZNاqاjذص‚ثخszڈ`¸*“d®j؟w{ں×è èاeٹ0wv,™3xا¥l“ٌّ*کY%/؟َOي'z}/o²بڈـْمپ;أ%%GL¨ن0£g7ه‹عqâں½ƒnA~“O¯; غµ³¾ڈ3bغz*زtGaû¢vکْ'o`a+‚;ءm_شN‚pّ6تّEëü’p~­‘أD~÷ ´غ&! ¶ن›Y¾ضب»‘8ش_?¦ك™سfƒàغاüâhش‍n¶™IEND®B`‚nً´'ًح`ع| §ےwZhùے¯]حèًIث¶…8ïي6$>5–,ث²²¸ôk~Xج¯ث½ا—ژْAG½£>G ج±د‌×;ês¤ہûـy½£>G ج±د‌×;ês¤ہûـy½£>G ج±د‌×;ês¤ہûـy½£>G ج±د‌×;ês¤ہûـy½£>G ج±د‌×;ês¤ہû<نُe~‎.Iذ’cضü~»\¶ْ']oٍ`û»M}®ع‡¨و×ïv-YeMہïهه²ذ?éZتƒ>UMہھ£>پX/“´چْق¥üïِ³َْ¢ُ?".kشچ]آw0ŒC‎¸ت•ھF‌ëU>ےض ژ«ف”vFY†ْ±*;G}چ¢û¼>…¼’vê«êw¤‎‘َْvYhOغ=¼Cچ†:‎ء6¬نî€ج¾9¬#÷Ir„¾گ»¬G@¨e]ˆْbƒت9êLWO¨³â%³üٌ4‘ü؟”ü>êo،س#يd>”T&N¸ن-‏"$آ2ث_nنé*rمي'آ ¦eW$ا€!‏ڑ¹‌§u"°ï¨OAmش]›4N¤¹ pً ÷)#‡إ;ظ‎tYمس¼9^ژD…ظ÷آ÷‘›دد’îŒGرàتق³‚“¢.ƒŒ?%wچ:+¶¦uش'€~Eآ+¹يڑٍu}Yƒç6آœé•Uîwپٍپiكُ§Hü£qtتچQ~؟â¯^ّµ_¯1J¤¢zش؛!L’¯³b™8vp‌×'ہقوُY؛i,جخWآ‡q¹¼%s¯ب»€غXآcBذ'ژ”ç(<ژلگ´5ü’آYˆ¦†ـàOIT¢خ¦a’àëژْ·QOà ثتژ‰¨P¼/ن2ع¸7ً;Nنںx‰Trتحg&€hذ‹ة^Y@‘·_:⨣H5رuش' ژ¤m^OOiيNءت®ذهŒِàê=¼ً6ù1®„£ناx:P$›؛£nإ;êةëeس:¯O@‏K¨ëçuêi\®‰$§h£¹¼§I‹ùژْ辑t<êP©lf ¾„ا…7شسنt?ŒّW¯ôIDAT.ؤü¥شـkéLç«%üD^ï+·‰#àê`V.¬8غjjˆ:R9'©حœج ^ئL-sش]dھ،WآlYjثVJx‌Jنâ´ك%üنï،Ny \ˆQ…ë،2.lMعrدظك³CâW¼خ rرVc—حص¨جVnHMش©؛£i4‏uشˆ؛’ô° جيe¯î—wSثو¨ل°‹‌ً»ü‘¨o?ش£هgQ?[­ُµل®ؤ(¤]u£ïê°¹—Dr­·ïZïOَ:6Sئ¢^8صzW؟$ل£Vx‌¾—£.[îإ;}WہئBه›ٍ(دچ9n/uھ«ظmNFڑû¨س­ˆ¨£!wcô<گ×c”چàُ¦ ْê£ئِu 9Ju¹!`k ش؟%”#“ںڑPA;éؤnŒE}ڑ]t‍q‡×ء*شلسئو•7¥¯ش ·ف+ش…­rد‌êl¬;ےhپG:ف ¯¹®¥ُـyٌكC]„y¹¶Eân½±Eز²ôو [؛&êtb*§)^MمP_›7›yئ¹'ûMS>MU ‌×5G8جz7@فJ×,™Z2م¬ژyZûY‌ه>÷¢‏وµyـرo£}Cع³&lLCriط„O؛قٹh \ü†n£4K5 BràDsَس گآZ´رnءك+xâ‌چهBک‡ttةڈضs€Cùe B)©½ضزةjزنtiُ6AW+z؟â°aٍ“لS[ِRuo<ه« }´ ttتMunؤَ’dK­Uuپ7آ9ê‏( ظ«ôIDAT™‏Bت“v—خx[zHE عة_قثدجJ£ض¦=ےا؛‎ ¨'‹,››<ص<–ى%¦ô™>ل svٹ±F=l‹l¢نs-ظ¥”ڈ´و[î ‍eوa5fاzQسçƒ?P@tf¼nإَ¹÷•أ,ےm"×0ِ؛وu#‚î°\رXQ ·×ه’ -گtءgأزظ—E’÷‹ˆ»n›Nظ³»¨g´حakkنحپµëض؛§جDl ·é»,ِپ´/3ڈ`#<.ژç…ü9Jâث‏Œى A،آ_أNëVحٍˆR4گ´صڑِ×د؛ >è„‎±p`ع`‌q،•Zظ’ر0:ض´zç—aœjm¬°±صM_ç{و,بھ(گëxإ‡lژ:è—¾قسکگ};ى©+®f¸âaتںع56l" ن ْ5ê{X2b_ /ڈ[‏@زچ{–wU „ْ·Xأ²¨tU-چZ#¬ء°oBؤ،•¸Lئ³¥F ‏v¸ûD·Rضك£@ق‰خگےجْ.o2 ôn`R`–—8ُQC£‌Hè|×»مإOث ±;تe¦Z`N«…©#ذ-¦¸؟Ciظ ™ٍڑ‎§,"Mاُùû¨û ؤëك –4ژے پ?]ى·Q§€¸çَChضQ؟Fئo£î±ذ‚سc é¨?–‍دQZG‎9pzl+;êڈ¥çs”ضQœغتژْcéù¥uشں§ا¶²£‏Xz>Gimشمkèف5pmح:جةRجHHˆَ8z‡‹ڈمgv`juہہءâ {لE•’=«ƒُa·°.VNثïFV«5Z‡za*رؤِسـP´ô褷§…âگم? £ZظD]w¸فˆکoAَc­ْ€(ق6ِ}‡شIl{ژF¬°yDنًO=‘ؤھüتZƒGِس÷† Aك‌´¬~¦H·¥b+Uڈ…ؤخ‡¾´فus‎ززث}v”€اfIv/éQ}†DMشيT›ا/€ء!Iëـ•v–شصء‹،nwش³َHéغ@فًٌأ?ق-َbr'&«HكقF]‎¹´“‏ي¢gكکv9ôIDATtT›¨›·»±iإ‏ ^ç.s÷w'‚ط¼vدZ-إQç6°œفض-pے¤أ‏u^·-sw5ً‚جuف7³­ُZ½چ؛Mà‍ىë}M¨…؛Œ3!îکüو6ب.âُk|.J\ژ؛2»،NTّ%¾–2ً§صˆىù] ڈوèؤB®L%ْ…\ؤûèb ش³6·$f9Voî´¢—ل­—û_ڑ]وثg_üآl¯G´نں‰xN¼pç ‰ uژUµب†z ÷»¨³ء,T§ں•ˆ6p:2eأ›بQpu—RP¸«عpxپ? ‚ë'Vس±ëنaoGرژvNˆف÷’ˆüF'ُصˆz¼U(X´ 5;o]3 wy]?)nق2شر ‰[ق3¬زGâ=ش‰¶h~hhم@ِ3ƒك@]؟§h¸خ¶¢v$3:xظoûP›قشc¯پ:â·BAB»م°~ج%C· مشéAچ LO¯>يئ ~2ضخںu‰÷PWfكٍàvƒL/†:¨vRdھ°9¯;lشٍùMF؟±أ›éبژ.­ً?طP،à )¾x±‰2Jâ¹yحs.°côq¶+_¹ٌ„+€‘1¶دقذû<´ٹx-بFâ]شةى{ڑلء‍i ±ں½µcb%ꤛ¬’کZ||h•S¨)ٍYش9?û®¨›Tد „‚âھPد_فDحرƒ‘ْ–،شىSً:ي+êv(م.ê)ڑہ‹±zC›M گإgPs^wش©‹Aؤغ·—Uوƒ‹‎ک÷0‍ü؟¨³9k69‌بâ,9“¸UQ·è ÷Q÷O¾«7P÷à ْEيJآêv‍âڈ§ءN!â ncِ/،>Zآï­ ّؤë‘P"’IQ·iç>êخى¯ئêCشُ°!4-ـ€h­yفO×| O‍?E. qˆxںx5گةحy½EUcد›:¼uQ رêذ•اٌ¼b@ب!®' u‰#PWf9V¢nضXôV.بu×لU´؟َ*Jfخ³l€ثQ×شسل]¯*Q›oذ8 G†dءذ„üƒ،lغشcح‍k"/p?`³ے،ٹˆo¬×¥م4à…\دâ\ù`qشU †G CBFط·ىًzp“ِ"=±™·Y§ج6†:×g>ذح ‘?†DçuPœٌ¦‏‡IDAT3ظض"tغpدچ¨غ×دمTm„_aہü ¾“r¥ـsگœù7;…ں&ˆBجjK>‹7bœ+h؛ûث6êaoگGn^شc$vش…<™ُR~iœƒُtW5n¸‚ذqPTgü<<ƒîصؤغûëwP/4nفإTM)A+™m©ج¼گP÷‘طQêd;&î7êô¥±K=üP~ٹAK’ًظة{پف†€0&Yy ¯§ذء’Kدe— —تëiد,(aBفIôyشة‌إج.¹”¹كœ،NW3صحح‡|ص¶ôrs“;‌ذـصnإ°M؟¹جDكً›cùgو‏8ù خ|êDLةS¨‹^ظ\[¸c÷جH‌ü$‡{ه!kل™=uً9qأـ)،ْ5/ tشç…·ِ¶£قQں#وطçخëُ9R`ژ}î¼قQں#وطçخëُ9R`ژ}î¼قQں#وطçخëُ9R`ژ}î¼قQں#وطçخëُ9R`ژ}‏™$±ُè<;IEND®B`‚nً‌N؟ï<‚'يغOظZک<#ذُ®ے‰PNG  IHDR€{¨iT pHYs.#.#x¥?v MiCCPPhotoshop ICC profilexع‌SwX“÷>ك÷eVBطً±—lپ"#¬بY¢’a„@إ…ˆ VœHUؤ‚ص H‌ˆâ (¸gAٹˆZ‹U\8îـ§µ}zïييû×û¼çœçüخyد€&‘و¢j9R…<:طڈOHؤة½€Hà وثآgإًyx~t°?ü¯opص.$الےƒ؛P&W ‘à"ç گRب.Tبب°S³d ”ly|B"ھ ىôI>ط©“ـط¢©چ™(G$@»`UپR,ہآ ¬@".ہ®€Y¶2G€½vژXگ@`€™B,ج 8Cح L 0ز؟à©_p…¸Hہث•ح—Kز3¸•ذwًٍàâ!âآl±Ba)f ن"œ—›#HçLخ ùرء‏8?گçونلوfçlïôإ¢‏kًo">!ٌك‏¼ŒNدïع_ههضpا°u؟k©[عVhكù]3غ  Z ذzù‹y8ü@‍،Pب< ي%b،½0م‹>ے3لoà‹~ِü@‏غzًqڑ@™­ہ£ƒ‎qanv®RژçثB1n÷ç#‏ا…‎ژ)رâ4±\,ٹٌX‰¸P"Mاy¹R‘D!ة•âé2ٌ–‎ “w ¬†OہN¶µثlہ~î‹Xزv@~َ-Œ ‘g42y÷“؟ùڈ@+ح—¤م¼è\¨”LئD پ*°A ء¬ہœء¼ہaD@ $ہ<Bن€ ،–ATہ:طµ° ڑل´ء18 çà\پëp`‍آ¼† Aبa!:ˆbژط"خ™ژ"aH4’€¤ éˆQ"إبr¤©Bj‘]H#ٍ-r9چ\@ْگغب 2ٹüٹ¼G1”پ²Qشu@¹¨ٹئ sرt4]€–¢kر´=€¶¢§رKèut}ٹژc€ر1fŒظa\Œ‡E`‰X&اcهX5Vڈ5cX7vہ‍aï$‹€ى^„آl‚گگGXLXC¨%ى#´؛W ƒ„1آ'"“¨O´%zùؤxb:±گXF¬&î!!‍%^'_“H$ة’نN !%گ2I IkHغH-¤S¤>زiœL&ëگmةقن²€¬ —‘·گگO’ûةأن·:إˆâL ¢$R¤”J5e?ه¥ں2B™ ھQح©‍شھˆ:ںZIm vP/S‡©4uڑ%ح›Cث¤-£صذڑigi÷h/ét؛ فƒE—ذ—زkèéçéƒôw † ƒاHb(k{§·/™L¦س—™بT0×2™gککoUX*ِ*|‘ت•:•V•~•çھTUsU?صyھ T«U«^V}¦FU³Pم© ش«ص©U»©6®خRwRڈPدQ_£¾_‎‚ْc ²†…F †H£Tc·ئچ!ئ2eٌXBضrVë,kکMb[²ùىLvûv/{LSCsھf¬f‘f‌وqحئ±àً9ظœJخ!خ خ{--?-±ضj­f­~­7عzع¾عbيrييëعïup‌@‌,‌ُ:m:÷u ؛6؛Q؛…؛غuدê>سcëyé ُتُéفرGُmô£ُêïضïر7046گl18cًجگcèkکi¸رً„ل¨ثh؛‘ؤh£رI£'¸&î‡gم5x>f¬ob¬4قeـkVyVُV׬Iض\ë,ëmضWlPW› ›:›ث¶¨­›­ؤv›mكâڈ)ز)ُSnع1ىüى ىڑىي9ِaِ%ِmِدجض;t;|rtuجvlp¼ë¤ل4أ©ؤ©أéWgg،s‌َ5¦Kگث—v—Sm§ٹ§nںzث•هî؛زµسُ£›»›ـ­ظmشفج=إ}«ûM.›ة]أ=ïAôً÷Xâqجم‌§›§آَگç/^v^Y^û½O³œ&‍ض0mبغؤ[à½ث{`:>=eْخé>ئ>ںzں‡¾¦¾"ك=¾#~ض~™~ü‍û;ْث‎ڈّ؟لyٌٍN`ءه½پپ³k™¥5چ»/ >B Yr“oہٍùc3ـg,ڑرت‌Zْ0ج&Lضژ†دك~o¦ùLéج¶ˆàGlˆ¸i™ù})*2ھ.êQ´Stqt÷,ض¬نYûg½ژٌڈ©Œ¹;غj¶rvg¬jlRlcى›¸€¸ھ¸پx‡ّEٌ—t$ ي‰نؤطؤ=‰مsçlڑ3œنڑT–tc®هـ¢¹وéخث‍wç|‏ü/÷„َû%زں3 cHRMz%€ƒùے€éu0ê`:کo’_إFC¹IDATxعىفïUغJ×ئل{²ٍ‎ر[ءQ*ˆ¨ ¦‚ک bWTTT€SN8 T‌ =ى÷ƒ¶‚P$ظ–هً»ضblK–F3ٍYgnï B+3‹%إ/IC9-µµِںHْ*)é¸ IكC³wش.tًو…h2³ر ÷‹-%}¤ :M$]u<ھ"€€لًƒ؛أ7¥‘¤ں´'3‹TIْ¬b®8Ycûٍں©¤Lز/ے÷â=u ‚Cطلط+&ŒT„>KٹüكQأثSI¹ٹ/°§’²BJ+¶¶يXز—Jû!ٌںqه}R…~†وo¹M €àگx"آِبCIك´^0،|ي¨²/©ـ؟ًُءٹm;ٍv«=D“ê%h¯±û\/@’تُ(ے}af¹¤¹¤ïoqظک _گ+ڑہ>کYlf’‏+éVأU¥ ¸¯cl×بج.جى·¤'لڑبںN%فI: !Ig‏ـX«‡?rےy[ا’.}§’nü}ت×L$=™ظo?®è­´5@p0ƒ^•2<-*ت%5=َ_ہ°ج,V1‰؛‰™ٹoêûîد‘ٹ/«_ذƒ·ë…¤s‎]ي#Sْبت×zّfR{حچٹٹ!#l®b^9َ}F‏ï{؟†±؟vdfsAگkI×~كz¨ى+Vô¹2³{Iw!„üکغœب‏:ْXز×آ-"©;ٌ–I:c},€ƒkَêî ء‍™Y¢"گذƒµi¤وàاجO*÷گ©™]ّ؟ث×f’nB33»ضK`مR/صA2،ڈG؟vںCںجl¢— بXEنقC #½’نzYٹوJزù±AXfw‌<ٍِ1د*J=hyإ‹÷dشٌـ”ً€!yّمI„?†lس±¤g½:rU<‏/„0 !LU ‚ّ²0·µ×‍xّ#رKذlB¸«¾Wa®bùI؛0³qaBّ¤",’û~¯ü}üµ©ٹ9詤O‏‍^+é·Iژگ!„ëذm±b'؟گTv\në_‡­`(•ًGDk ز‍‘™=ھ¨بûأ7’>ù¼{^¾ضƒ ے³|mھ"ّqBب½ٹب£?—Iڑ6½oلز·•¤كNù¤¢زGُ}2Kدن‏؛ـ«ƒ”Ayںx0³'_6وhظ np<$@ّc¸ِ«(ˆ0ِ‡j~T^«؟Wˆˆُzچr©¨ض‘wآ™^*xN¶¾Hق_¤b.ُ,„ذ¹ïBjf§ق‹%¯؟زKPdZخgûœnى?_|_™¤ï•ëگ†ٍJn –ô "èرt\ ?®ٍ|‍جىشڈ7ٍc¹¨\ë©؟gùْG3›zکdS؟†عكG3»nynBXlpٌc½¬÷³ٍ¾×9ڈsëإ-û“ٹ”دIَu'َحlز²ï¬قّ‏ع¦›Fـ±ے®´صه²Sغ×XزWoڈh…×gق6ك×yں-ُ‰/-ڈا}¢ٌ:¬p c؟NةٹغlشN~Cj»©دêAœت1~رK8¥¼‍‹¶›€Nم ·د%ف«کwNùDآCî/UQù#_e[o«tة‏c½.îkث¶,*¯»–@B× ï•›ظچٹًابجFmظ„J8¥¹T‏ˆ‎e©ٹ Kوïےة_ں¨¨ـ،B ه¹n¼؟`‍گhpسش`kt€‘عKة´î»مxf¾îOYيمVيa‚خ¹خyy@cشًش"„pZ{يµw†،œ®آٌ¶~ذfهٹو*'ظo2]}¢¯؟®Cا مھGںùë‎ش/کَ¸ى¯xŒ ¬!„@#`pحûœêُô]rں‌©ک'جڈà\½„نا}7ذ‏Rصآ•B#‎=g‌û8ے©"8“µ¼اƒٹyز\ز§¶v®جةwخ›ظo?–¥َة يUjج5x^، پHزة&پ ےçتC½+پ|8ہ‏کµ<WN‏·ْMنG’®جىظ/ت[¸Qفzçٹ7ـصXزَہkJ]ّ€™ °»‘·سُغن+مxہcًعhƒmg!„é‘„?"‎fXl°؟X-ل3›xذâQإSwهûâG~SŒ`>÷ـ.“tyDçYںOدûV§ًùôr3WQ™"7³بWزè³JإHإ\‎“‡/نû‍©XضهnˆFً ™ےyصpn#ںïm*>iI`بC g~ى‘ٹyِhƒC^ش‏~¬´دت>ظ |Pû$y®%ëص$j_–مàUJàt™ûحèشخT$‌–µسCںخt¤m$oڈ›عد\ث+wLپDاـ€#ُـî‏*HVڈHj/6طeu§!„´²bاhأأ©¨rBبCSI'7Iµ Hâء• 3{V”™َّ¹؟ِےTجKزي²ھ¬)——‰µظ¼ïد†‏؛ِ‏>ر€lê@ I÷*ضية+;ِ‹u¾d ڈجlزw‎œ† |-é؛a ]«!Uنغ„÷Bفء†;µ—ئ™K؛ِھM7€²3=T:ëPزژ}~k9§Tف‰؛¼gIEٹى¦c‌©ب÷qصرڈ&fِsIت:‍[ضGQ¦—ةصMِىJـs»ù1œœدے^4<ُ£ç‏&z™o‌VآC¬طQuef_$‌ ´ !ججىت¯}سq—÷±yeY›©ٹ9ôXEژ“®مٍv™ھک_y ه؛g?»­=–¬»؟`fضٍـMد«v°§u÷ي¥bFKvںK؛\ـً ü[uزآIا>عژgB8]±-®5Pؤأ-د-ƒ*÷ء7_q_‘_£¤ه%§!„إژnHmm´r;×عè÷’‏s؛j©#ككcG;ه’>u üژqضط'‎Fœêuہ%ٍںںد€Uُّ.*°3]S(ô] ـ׬دvلH:¢™‎Vsبهےض Vشو¤g!„©د-?«گf™T4Yrl×*و•ےڑGِŒB¤b^÷‹ےژj»بU„-¾·ح…{ذهظے¼ !\®ذfصص)Nْ,»س‘MّشVش îمژح\+Nق{G‍ْX‍´¼,1³xص;]ص(.W ”يcfgjKœk³’@ûٍ°¤ےœ¬s½C™™‌z;5µ}¤"h4à¦v¹,tسَ³ ہzزc8H¯ض7<5ëYUمAإh¦—ص®´½ً‡T„5‍ج¬\jf¬×K ¤*وzثcH<0¯q\3_j¦“؟ےچںَ…™‎èڑأُہL\k؟>ثظ|WsنJ+خE8آAv³nZئ/b¶¤3أہچشd™ُYتئƒw-Oڈ‎=ڈ†§±F/9يٌِمYاK&¶UھV\°T~$اyصٍّ÷¦ح¬unسج.ô2ك:ُ¢±ڑ——Z$éءج"/|0¯<—ّqإ•×Vے®Z¨کںJْ¤—Fkث‌^2·-myE’كµ}'‏¸:عزًش¼¥دMü,ulگ,„p×sغïد%Gr‏مژç6Ycي{د÷ثجّ¨ذإ«W\ش&‏G /‎S‎أ—)yزë0آ÷†}اzYٌಜ[ُام=œîصہû›ûïٌڑغ•U@b3û-é©زو I'^m$—‏Tٌ¸ôç'>‡فdل؟#Iڈe°§£ H\[¶ç\ +TS$غd“¥?d0اj7 qnmm›Q3چ:‍û1àû¤×i´î¾6©قàف(«WŒ+ڈ% ¯»”‏F‍ُz5k™;؟ھ0FژFشٌـ“mHأ—ذ9¨6¸Lضَ:5ùE×ذإC±ے9jyظ"„p] Dµçs½,…RصV‎Cعoء€رہû+د}¼نu‘ٹ&¾û6s½„5âUق¨Vن¼هeMK½Lجىء—ً¹iظîKهك¯خ…بٌHh‚قm”ü>Yاsں¹ 6ھ‏af£عَ©¤3_6هAحءچûB^غO¤—ءحoأï•¶jBHC‹آuل,„p¦bY‌L-=Z”ي9iZخ¦©ڑکظ…/3[زھa xS¢–اس8è«‏Eô‘ےN‎çشأj‏â|&é®لٌ±ٹ9خ\حصAٍ=‍s:نخ<ط<ذٌ‡™چüçعئ‏wTظvBّ¤bi–dإ·œWعoزٍڑ¶ذح­™%!„©^B iCًçصك'´¤ِwù.iBب=0nظ‏¦^‎أ•ث“ج[‍O÷xخYںچ*!‰طزآ¼ٍ|نيôUK–ƒ1³TزBEُ”¦%rZù5™«œ«!€Bک™ظ•ڑ—–¹Uى™ڑظ؟¾؟ْë"3‹تkGنm¸، àحJjG’B¸«2³Q¹چ?·مB"ٍ&T.6ڑچق_×ح ¥¹ ¥،êƒT›ُھ£–]L[ûï¬-شBHحl§‎}ةَ‘–دد| ™Y"éQحٹUچ%چحl&é²¥bJSûe‏¾كش0ںBXx¸dـ°‹sy¸أ}ixحںs"r<2ڑ`©…†{4I:‍û—¬أ—#©کƒّ¢bb3ixiھâغّ™¤Uجچ¤«LB¢³‎c½|ثے?ê‍ *¯أےقbû{[ؤق×i‹Tث+6 ؟¸يقQéكZ¶½ë¸._‎÷|ةû/´›yطR®†هRj2½‰,ھ‎²:.حl"éaہم›¨‚œ­X d.ébI^َْQيٌqي:wِڈڈ»î„è-ë¸'ـL—~Xچض,إسهَ’9€Nْک¨ک´MVـ¬‏؛+كW¦b‚ٌgaNë®شِc“ك#­¾Diشز‏كڈmخ®ز_ü¼â‍mQîO*&âJڑ3‡¹u‰^‚م†ç3I7+\؟ںKقç§v™®¬تVY)أجnU„/†Iz2³›ژم‡Cزو!dfv#é¶ه:ح›ئ\گم‘-ikn‍ف7‍êحoS]ƒٹë8(^ِ‏¶ا¦iلٍ@خل©دv!„س¶×ه*“ف^aلJEّc(±ٹةإ 3ث%ح$ف‡²\ëymآْرXEàf<ً®«يں©¨Jpwب•A|¹گo÷أزب®*لکAûممt]IكûOإ÷آl÷ù¨ل©³¶~è} ´Xٍ ؟oيآفPA63»ضvآUWfِO¹شLث‎nQ¹Uژ‎فô؛;3+ƒi¯ْ،–Wi‘شùد†'ْ…ے¤ژ'~؛عz¾açں¨9´“mû†4 ®ے¨ْ¦هe‚6¹y–m•ر[&زn؟¹½ £#h¯¨ëI¯´p«يL¸×ڈمBEa&éو½د_ّ<ط•vَِطكëـجîu`Aںô؟علکٹ+‎q®"²8¢ûعïَs‹ا—¨g4ف.Ci¹ؤTC¨¢<¯إُر\فKْŒû]کک™؛B zYFçsأ±&’ن!آ©¤çع5‎ى¯[zû°¤³ômجّ ü‡ؤ!ڑ·<>`ك>ê?انéْ°HV+8ïù‏à‌2³ I؟µ‎ًGفDزoےü{l÷‘™=«ک‹wüِ‘ٹ¹¶ك^ydكmQV²xز‏وqا*–جxhق/!پْ5‌y5‰ب¯yز°m9œ®ً>»؛^é²0Jل:N;ْûطا‎Nï·fضُ‍e(i¹ژOf–x`oعr‌—^‡®بب;DWŒµ­hK‡إµ=kكً;‍‏÷XاoَmُKے êْ³{؛((™Yن‚·ZR!dث®جىyةœذ[k÷[µO|ïR$éرCر‍عمZEEپرپ\¢‰¤gFax©¤ث%لé%Lًk…}‍ةطڈ}ى?î«owîRے=ê¸W”!گ¹‏پ¬نƒ؛«Lz4êD»O/¾َژç6Yمê¼ç{¢û%n“¶®ؤضb•u‎ہûP™|‌ب!%*&اo¼فo÷‹;´‰·´ث>èU?ٌثû‘¤[3{ـW0وبd+¾.•tê_œ_€ٹWظ·‡ط’‌çعE*¼؛حؤجUTZع÷ط؟j™“N+اwŒ‹'3‹C3I³ك3/ےٌAزڈ%—¬ر¸ع})•cے­ْZ/÷زv‘“%%e؛ق؟ي?<²c 5ّڑa‹ژ—<ِI·zغv]«z3گ^…?’;´Hإ\ةنچ¶{r ي^JTT¾Hvش؟u8U?عŒµم`ج1ٍyâ&ے©ü{&, mTç¨}~µٌ5¾„ز®ïٌ’¾‎d*ھغ‌¬طFei¶®غ¼يئق—T=¼µJ jyض~—عYE,ںـفb[$ق£#¹|‰¤كïe‰¢ ¤-m'I³آشأc‎=·¹hظgقذbںûكُ},U`I;ِْH‡j’¤¸e)ک´vف$5†pyِآ+پL›¶kê·‎اYه?&ûتشs‎%ً&يr¹„چژ³c‚£âقا´JA¬-U½8آًG)ٍ> صëY£‹¶×•ص%¼‎ڑئBVû{ن؟سعû]¨کيلt¬ً¥ûôˆ.كyأcy¥؟/»F“²RK¥zHسv©/ù#3‹?ْƒ7~—}­z،ç’¾ëpض4غ·إ ¯5´oش2€¯حىKاُˆ‎ùàï‌IْWزgnظuخ%‌sƒ{‎³¤N|àdقF?%‎مm´J_د%‌• ¼o>y:ق`‹†اF[:ـHإ—¼Oژ¼ح ‏بüü«b¢9¯]‡ےhµ9صU$*¾ل?°-b ‏ب½-~y»d•çbےùاغ#èءکSوك‏x0³KےüOIK^غp‎َژ%dت¾i؟ث¨نZaNف+œجt9„بج&k]X4œ×ƒ™‌TئCضِ¹ل×ًٌc¥،خü&؟é +ُUآxüسS3[ ü}¦صتîŒz ®سe7پ#i÷iQ fé  üگZ§­2لڈ”ôRUsI?$-؛وf|bo$é‹ٹ عx cNجى"„pwŒ ^Yn'ع`7¹_‡û%َ>‹عûNT|أ“k11³!„ù@mٌ¨حأ3•وk¼wى‎ٍ|€¾™hà`ج¸¯<™ظ§آـ؟ط^mمں•ë0Rَ¼èbةُK¼ïؤ{<دûھ”‏=¢ëw®×+§üô{ùç†×‏jx,Vْ¹ِ؟›>'î‎÷£¤نCù¨¨œْ n“‰¬f—ê^ f-!„<„p¢îه{ضµگtٍ–B !„éذmïcن„ً¨hْو}“Lإـإے…خB³e_جُy،yل2„ًIإ…سپژûꈗفط4ً0W1ç3]gقا¯ا‌ٹê)7›ِ›پعےJ›}A!é“·إ|‌ CYلخûوTح“شëکّ²>]ï¹kêغ.as×´Eâ}¼¬rَ}Ihٍ³c›Xإ’/ٌ‍ئpîchiں3³‘™=i‎ ف>%-م;j¹59ï¸G,B™WںIز‡†›ص™ٹ بL«OڑدU?¦„?ZoB©·ëbà‎^°كLز4„ً&*4´Qù<غpW ïç,ûêâ^s£"pp·ة\ƒ‡ANTI6iù²§:لظC®bnىl“¹1ں[½Vبة7è7¶إxأ}\5Oèث] 1/÷pؤء¤mûu¾kêk^…¥m<ج7¼omس4„p½bk¤ي-‰µصk·âطةش‍ٹ:ِqم×‏O(وcثخ*&»§^*&n¸ّ¹¤´£Kھ"کذ¤ëوq©وؤK>@مîُxتHeئ*ت»Dµvû_ظ¾+îw!iQ)¯ôU/i0u\ں…ٹN‹èّ35‡X†¸îه€™ڑظM¥چV¹A”يô}أٹ}ْx2maiùآ‌™-´ù2(كô²ؤہء«Ox®)Wٌ…كtہëP.حٌـsçfض+ن!‰غCi oڈ\إ¼ـO½T®XW¤×K_ ¸خ'*ھ¬<ْcهµ;oظ&فC€™ٹPQîثث$z™›چ*ا}³fµ™ôH¯غç5^;Wsکë\ز,„°0³ٍ±;ےû،zےŒ“·ح<ُA‍س2¯‏!nْہ;ش%^*ƒ€UŒTضµ!œآ Xدے9قgظں[yًًS“ىùغ'QےًAé¤دـب¦×¦kَ¶ثç‍“‍çy¶î'k´إ…ْ‡1.½ھ‎؛ïy­~aک\[4كD‎C R±,M¶اûب^ïƒ ا|B¸®ŒپO¾ب³ڑ—jىWô›e2_ hèv©AŒڈً3ّOھ´{c؟Zr/¯^k©(@گش?¯>ًكق| c‏AEبa|¤×0Zل؛VïهYث~F‏{لم7oے@€ل¥عAّ£نلƒtƒ]Œژ¤]ûزآُژï¦çv±ûm±ص LCك¼Tû¤ِ28¼Wُv‹$]„ٍJ‰¤£دgRمھغ’x0iHٌ‘_أêُùâ؟ے­¾ v}و]يB¸ !¤¾ح_ו0¬\إR#ùژكw“* ة،7ھO,ڈِذ6+ !,ش?ˆ3Z£-"ُ«„’ي(S7ي¹]¤م­ü°-çµPL[؟¹÷¾2’ôطpڈع–رہûثقة5½®^·_j7ہ€أ؛/؟y؟K>è‎¾;¬ذWكٹ o›‌]ے‍غ}]مµ=كمrخغ؟ï5xدثہülx,زًٍO®—J’¢عّN·xجں‡ع‘™Mشة§Cûïْ}z,éتجےىX,i—XحA›`8ûھ°P؛ك`غّPص+Œ{n~³مأ]ôـn´ئk؟ُط؛ث¥_ى›غXVنhî'-ڈ/ إجC¹W•ˆ{ô¯M$چùXExه-‰ë×µ¶ôس­ے‏¾d?ma¸Œ0œï{~ےإغئـ®c•ض•ي¸ْ‡üüiںmk“ءm¯ُ¼V÷û¼€>ة{n>z§÷“¶¾›ظ¸c»M‌·\‹mژ‰d ‎Lقز5¬چي¬ٍïê}mdfمآL-لں%ث?‎" g¶د7!¤ê?ة~ب¾ِـn¾§مM{n­ًڑ>ص?ٍ=¶إ×مث{¼™xک([زê}mوغفضْS½ ³-v$شا‍T mص–ص^_V¹i¹^“ژ÷b ` imbooاٌ–uأه_ِU‘هك‍غچVxMں¶X„ٍ¸œ?¶ط.oص¢­ّ2)ُ{خحٹc&فâک}د׫î—ےN–\دRـR¤ـOغٍ?Y!% cq ا‘¾±vُـ.÷ٹ(o¦/ّ2QڈMyكŒ=شًu]»‰÷ٌجے¾َعd…~ٍk‹ا°ڈ™قF5£ٍ^ًeچ1PVw¹¬îgةٍOsIْبç00ˆںrے{cيعwùڈإڈ9سكK8 qج£#l‹?B™™هêbIt8!«]¶ظـج25Oü“t­bٍ\ésكVىW[:ىx ¾2•ôxؤ—/!,jcw•د‰±™إ~يç’’BjfغـK13këx!„س=دSاسiل²e»ë¶پB{jغëژء{Zétè/م8¶bشs»½r¼ أُv‎eƒم9iدk:ز; €¸ïj‍ïچ½*جwI?B¹/ “¬ذ'يSôûg q47³S!گè¯غ\’جl\ylص><–t'iھ—ه|ئ-¯]”cœ أگàعمr#uظkع¤çvéىf£غ,قب¹ےçك^î$‌«9ٌ­V¼`¼ئ~çk¾~Uٌ€÷ص…‡@6¸ىثwے‎gù—B¾â¶_T,é“Kڑyˆ$jyيںjCّ(6–رأ3³ر›§o¬-bg„؛¾•Y’÷:<ذ¶¤ذ¸ِ÷:Ub~léگمپد?•t*ivD—mQY‰£¼Fك×ط¾~ïûعٍ؛yuإ ہو2ڑ`+’¾®ٌMûc÷ـî'فèّ…îش\ح¥\¦O?YX_يد!„©ٹ%Qژءچô'ؤV¶ا|چي#3‹*ڈ^“×غƒ€CُـnٌغbD_x÷¦*&‎»ْFز²ي_غ…2­JXY-¼0کآLإ’8‡¬Z•م›ےN½½ë²ژ‎$ق–‰ڑC5سzذي#cطXFlإڑàڈےôـî›™R;ئ=·KقمE÷ةےQل.„گ™ظ©¤ç†qr·dW؟Zے،؟—‘B¢-±B—f6ض*چ ôY0ُkiùٍ/«|vŒ» !ج‎}F’âآŒ°¹i‚ƒ’¾ءsJznë0'ت±ڑ\ز­™}UQٌ!5³©¤‡>}£¬جQVژ!ججىVاWaه^زي^«³JUژI¥]gµë·Tiٍ¹ِ÷,„pي×ٍJز…گ?)-l]Düسïض¢2حىآç¬Oô÷2+yث>2ے‎UزطC¥ظژ9QXy0³±/Sزبأدz]1م³™=ڑظSS$„°8 ë“©‏ًc.اىMهٌDEه’±ںG¶و{ـy[>é% —•û!‡/¦ ق­µ؟oحى!„گ…N%]Vھm¤-ûبü÷ب_U–ƒة´‌H¤"شٌ(éة^û¯<TT$‰jغ^¨IŒôwإ’C’J:i("QVّکصBه²5‘‡Aھ×و•Jبه§؟اآƒ%Oµِ*_G€CBکëïتO(„pW ¤-ûب0ت¾–4<¯ت@H%}ïHX zچ‎ط¾Tخµ<كجت10çc ؟آ¢2/ ¨ِ0iyîآج~ù\‎‌ٹہAند-:ِ™کYRخ·†ffِMأ+6±è_جô÷²*µoل®د†>÷\5ز†‎Œ;îu™دُا•ë\خء?.9ق¼ْہا%™xƒچW8§ؤ&fv«"s7tPآ.ç+Sظ!جl®"±Xم­IO-د‌.$C‌ëXز­ڑ.MbI>¸oڑضZرmث€^ّ¹W;ٌ…¤oا¸ذ ¥w*ûھقˆ´آ5ùùf’.× ^t]م3UزRfv½نطbے)ڈ'كضض°ة¼!ب’* R17‍‡وfv£bق7]ل ûكô²LŒ$M%=kُyغmةTجغvµG¦صçس—I7ط¶؛ôث´ْ„دû/;ئ²jثـأo‘ٹ¹ى¶kگ5…U>´يفCدZ-üQùء={ˆdcfù1=ُ8¦±¤'ك‏àù¹>¨Hَôي¬Wfِècا8’ôغ¯s<ہ¾‍}_}ڈ7–ô8à9'~l±™ُ9¶r üِ ›؛T2hَà=îT|Yےr…}ژ«x`d؛آvsُ+œ°PQ¥dھ¢ء¥?V‍Wودں¬ًeûlكؤ‹ ”mxس°zإ×ژmےç‌ںثt…ً‡ع®دا†7(w– p®±ٹàإiں%:¶pLf…¦‡:Znے±^ض&ZGçZI¾$حأ@ç;ط¾*ç{ںë¼,+وث mڑl‹TS¦»X oV¦ل*àH…r3›ھ}iگHإüن‰¤³W+ˆ«ثہّûج—T‘ٹ21Œ%}ixحOsض©ٹھYأk*} 9&FZ3ذâإتehf-KبŒ;®gZ¹®'‏ûAفyپyغê'kiµًAyپتشُْHEنسKaj¸²Ff–­¹ ïقPصوٌî|~ƒç”‰ô'œ1W{° –ôB8[c·ُe`Bکْ=¸é><+أbH÷ًù0xL|•t½وçS9ك‌ھ،عٹD¢¯knfêفdê¨خR¯r«î‰ُ™¤ûz5ژ\H:o9ّHإdْiڈFµ<>W‘ھKâe´dںWf6[a­£]wذeيںھHQ-Z¶ڈU¤‹& |‘÷‘h€s­†¶ژ{£"½”¯q®ْ‚™]oôiêث¹÷»z)?©¥ŒWhçIںّH`-Mً®-´|îڈ~ƒ÷hھbn9ny~ـ0_ڑwى¯mœ‌ھX5،‏>?÷yٍ^làvàف&f6ZهK‎>ك].س’«½عت—ژفن û\vN‌U]>Vv6Vûdzyہچ'êopي)£¶µhF«6ضsy)™–€;Oْ,«قp®صض;عU©ر´™-[؛¦\‹ةج¾kطê¯n¾™^/7َ¥é&âپ،اپخُ‡ٹ`Eس¹nô©ïïFز]ث`ڑK؛ô4ضUG»اf6a)ضر كH*¾,>âزBْS-âLيََR1_:¯xّ¥ِùقؤجâْـjاûd»8OEŒô²*†¶<nµd¥‰†ًاiاœôxةک.÷©{]’¦ُbuj'زوl•à†؟YW¨â|أئ¾ !œ-›ذ÷c=U؟س¾\u<7_ˆèq‏CبU$ث‏/„pBک†®+?§-ًBيI´ظڑç:كrں+زُ²%Œ|=§eي‏چڈ#ض’ذïZJ؟ùمtTù\ى²e^=\ _êï2êxںٍَْـص‌¥ک…VZف¤¬زU•à¾Gƒج;.\ںNگ­zB5wK:Qt م²³‎{,تA8×ٍW™wو¼دہي¨›,ةسضO£ n<‹uBG•vں©£نرگ7Bقپک&x×l›¼±¶بznرچق6ںںىZ©à¢2G9ïطص¨2v~›ظmي}زتûD’‍¼طD/f›ظ­Wْxشf%†61³§2Sàçù¬îًاXزoI_‎،®ًUBH}ے¯»Y§ˆآOîŒZ‍ں/[n¥إدپ÷¦gGد—|(تM؟«#د6ـ÷‎ژwع7”RéىM|“ًإ 7ھ]¶فœڈہ‘‹ن8F\ٹw-غ`غdںîغO=~ا^غ2‡قط ںk=ي3eک£kî=ِ‏Wِµ 3{®V¨„@ت×<ّr-رccbfO*آ:ـگزHEوQ/!چLحلڈ[!–¨ز6]ں_هu¸j9ے\إ¼üُ:üqة›‏طàF¼ً?و\”ôگےأہثؤ´uè´g§:ذçf–8h6 jŒ¶pچBبح,mùûـc—¹WPé‹5طا.ق÷PU!„lƒ¹®}/}’¨ا<ه’ùءEں}ڑظhأ9¾،ئt¼ء½%فàKêïe¼¤fv¢"¬0®÷G3›„ff6S±ؤJ[؟Mkے6³?،ںSپ‡‘ï+1³صو¸=’ّدg?®èˆڑ5ھ´eھعJ~~Oz=O‎¯?قض×3؟±ٹج_}]Eّ#]÷`?.¹ٌ-ْv,©ں!ننCںˆï؛Aےè=®\خ|ƒzW'ے5D_é”}عl©8rfoْeص %\¨ے\×hدا½چ‏›ِ<¯‘6ںےآDEإƒµ…Ca¥vت%‌ùr$·z=?{¥bٹµ1’†"‘¤g3›ْr3هûœڑظµï7Q‘™½إ¦½ !\ض>#لڈ¨aœvچےثتُ¨ت%ف¯[ُ£êƒ:V{‏@¯6خ[ِyç‏kہمفd_]‌|›}m´‡6ثùxˆ|ƒmم=û.$‎ى»،O‚ïœ1:ê±ébKmٌُ@®eك1‌3 :û[l…g_ژeBک‡>Iڑêe.6ِç2¼ë¥ د=ّR'xX،ké™·ًzض‏ک¨9üQ.ا“´ىoو›H/ء¶\E(çSلعج’تRوïµ’ڈoœ2Tv"قءچlبk¹ةہيْگ»ُظ&؛¯y©‏¾›ڈ´كھc® TT¨؟ي¹يWmPل~£‍غeK‍ï;“¨è#ُںدK‌÷ùج—_)+qL|îu¦¢¢ؤج—شْêدد=„PnسنGK?¾ًًآe¹’GaلKد\©yI“c¾÷Lë+–کظEا=©¼كDM‎8„0­}¾‏ًëùu;×ë ء¢¬؛²ٹڈjں”د*{¨C‎ص،\ثd 7{°=ں÷ُئë|مo›OngêW‘flf—ُ ـè[éâç’¶بحl®~ل¨s½,=±ڈ1‌¨_U”¥يIز‌¤o•q©c\کظBزM½ٹ…W›ّGإز<¥‘ے^t¼×DE¨è´ة%]ڑظلˆنˆغ2SüX4ôم‡Z{µُصْ= UQ)¥lû¹¤¹WoyPû’£عv‹آ‰^/=s,r•M>ُ ´ُصYل¤D«?~û>›ئوچ_‡•xûز¾ڑظx×kf±X‏¯فo°يصژûïH‎ھ•d+.ر2ïyh‘ِ»ڈ!’K؛‘ô)„p×0¦#3{ز لڈت‏éû‌V–}i ~´~n‡®×= oك¯ ¶=كأٌقrةPه“ھ‹‍›اfv±أأي8™¯ط¹¤Yكٌى«‌ٍ Y¼حvء7Zْ©‚<–‎!„گzهژ›تëf*B ]"كWزشWC³آ'AگإپµUھ" ٌ!„릥¢¼آة“V[ظ£کY¨”جت‎کظµ–?نm>يsB@p(ع[E ق¹إغژv9aىإc.|ك`غ«]ôc¯ھ0ê¹ù‎ع"’ô°‡k·I¨ë‍®؟؛تR0ù /«¨àq].هBک×ِu؟b؟j پTِ5 !œJْ¤¢JI¶§&تü‎O|Y–YاxژT„?’U>g«ثئّR8¹ïg¢"ّ±j8ى²oص›®Hآًطïp ¸WL3ً~yُ„tƒ]ىdآط'¸bhéا3ُں4ژ¶ف·|n¯oذa±âٍ/e[,ش?ط5ٍJعر¸¾Pےùتث؟ô+©ض« q%é¹eة¯;­&‰´$R~….½*ب‰¤Km؟2بBEe““آ'ےt…ٌ¼jّCz]9هدgڑ/َàي³ٹ»®Pت2–\ ىW2ذ~â9nخىد&صFغ^Bأ«3<ٹ9*t»ظ°o3r«‏َ{7;n‹+¯J -ڈëD›Uے¸،ث÷م•<ض پؤ’حى©Z-ا«Xœ­¸ڈHE$Zٌسآ]لشWu8U¹Sعبض<يج·»َ‎œْ‚§¾ؤK؛ئ¾×د7صê•ه^‍µ^E Yلr“ë‏ر`ش6 ITm]¶dگ لثپœkقqَUـ\›MؤقڑY؛چےںï“ؤO"üپ%B33;Wے إؤجBکـ‡$Mzn¾è3®B 3[¨ے’3f…î¶q­*مZ»lü5^¤ُھكŒTT¹,+Qx_›®¸ںHEن´\e‌>­–j ¾¼R×vCڈçUاص,„p]ë÷ڈZ®6ؤ}éƒ؛ثµ$4تSثد-Cي•_د ـHن\سm£—ذ5ü$t3ہ{çثKج6ـحسذU¼²ب³`u—n?ٌyثh€‏m‏طô|¦Zmyژ6·fِ8D[la\_زص¹÷دTTًX§ںD*Bْ†ïgص€B¢ح‡Mç±hû¸ïNضد¯B•ھٌڑo{3T(يƒ¤ںدي{£S‘ˆiْùأى•®9 ƒژه?ک<ل•¶<=Dطه©هçœn€¤ح–پ)= 1aى_â|ضٍIآ\›Wً†ّ„ïف†»Iْ½ةزF>Qü¬حآw›¬بàء®M—I—m1ہ¸›ظ“6ںü؟a¥ٹAاج\إٍ*iڈ¾ٌT~لقC §Zmi–‰دU _ْf•¾›K؛,C{”tµو[و’خھD6ُAE¹¯ض عsگڈ:‍ثb¯[عر&ٌƒâذآ‹ژ¾o8غْê؟ô4‏LœدطصXإ„ٌأ:•¸ح,ِIوك*¾ؤ¹ت¶—âےُمï¾|©ُ'³ë"0‏kf·]KLTْpRéأZے›‏U©6oب—p™ر•q=^qLGْ¸ُ6yشو_rO‡œاں~’†N¼دهklڑèud!©ـO¶dغcû¢‏Dفإrے =)—Nٍ<إ“.®c&铇sَ1„گ™Yعٌ{!iفضU9dءًْثـغ¹mPô؛è‏!5:°s‎قq®WZ½lPس`¤د°ـچٹ‰ھhأ‎D*‏ےüؤجr“ظ©ڑ«ءV1¯ù³آجثêugfù Hإüص…™ةûqقً؛ر€ا‍Kڑz‎!L}|%ژk©کàدZ^›hّ•r&°%!„k3»َ>¾â5Œ$=ڑظI!÷~{-éعƒ!#؟داGق<ےركsث¹¤_’ع–›yXsـحTT¸ة¶q‎÷½X“s3›¯ZbاC“–§سm‌ب‘»W{(bdfe‚hU‍4z<ہJjfYثàںکظ÷u×iٍsmKڈهC¯ûہ1َ/كhَ%ھ"€£÷™ھ¨‏tُهSك¾ڈـu²ƒأ?r‰“Bnfس-´E¬فMêçق.9½{ëc'×K€c,é‹÷ûQاµةü5‹ع¾Rm^چçPعe­دں§ژ¼mâژد²TزOIَm÷ïڈ~"33»j9¨HإZnK›§{؛B÷ §ض§;µ‡@nح,÷5•Véh±_‡è@OùFيپ£GïkéƒھëƒlNàµآ‌™}Vw…ي}JإD0Vëثé–B غ42üqنmQت5p(+÷›¹jsھ>كw}رق³‘^B#ں+‎.Vw ¢¼·g*–ّت$eغّb؟°ˆT„W‏£×¯QG¬ِإںµcO+•PNعEûêث+ے¾T{x#Q±قسe[ءج&*’¢m7“إھ†wھ,·ض6جى‹:تءxâB—êةé&ïپ£o-*’ôىةم»®ے°َءz«ِf.’ء´¹Tٌےط“;®T„?°†# >نعrب،ز8¶»ئü+IشکتنKےّt¢—e^mV¦µ_V–JU„.댮ŒôRر¤ïˆôz.{شً^yه8Sùj(û1}¬\ؤù’*‘ٹآmهD‏Si¸hةحlتPéD¹™‌-ù`ڑ¨X&%UQZ§؛†قµ'”†.م6„©؛×d»’/?¤bM¥´6ہ¾®0`§üا!ح|n¢œ4Oن°*&‚s®ضىد©™‌¨ّآ{r€‡کjK•?Zع¢ پŒüزف©ّ-تڑ;ْg‏‎4SdSd¸a —-a0N‎ےے ےےےpûppû@ <‎4dddd8—))0l©45 <‎4dddd8—))0l©45 Nˆ©ٹh؛___PPT2001‹Dˆ<‰4Xˆد€àٹ_؛___PPT10‹? pµpµن.؛bboه.±6ٹت؛___PPT9‹¬/ب 0ز®گ¯b¬€ےے¯³¬€ےے¯´¬(€ےے €ےے ?ظrع% ؛^Type your title in this FOOTER area and in CAPSOظ ع=ً„‌َں¨'Procurement Overview and Tender Process،(((ں¨XPre Tender Meeting UNICEF Supply Division Copenhagen 11th December 2008 Katinka Rosenbom،YPYھ,Hَ ں¨Consultations with Industry،ھ  ں î2000-2001: First industry-wide consultation on UNICEF approach to procurement Feedback received was a major contributor to UNICEF s change in procurement strategy from obtaining short term best value for money to ensuring Vaccine Security for children Result: Major changes to procurement approach Move to 3-year global (OPV on own schedule) Move to RFP from ITB for multi-year Move to multiple awards per vaccine Establishment of vaccine procurement principles Continued dialogue with industry through dialogue with current and potential suppliers, invitation to formal updates (April), participation in meetings with industry ،l,¥§‎جf‏جf‏'¥§جf‏ھ x َر›ں¨Findings، ھ  ں ’Overall there tends to be similar opinions between manufacturers. Multi-year (normally 3-year is considered best) Multiple vaccines procured in one tender Vaccine should not be procured as a commodity However, there are variances on specific issues. Public opening (ITB) vs. public posting of awards Our procurement process is also informed by inputs from other stakeholders: Benchmarks with other buyers Review with WHO Procurement Reference Groups etc.. Our donors commitments and funding also influence the horizon and types of procurement we can consider embarking on ،‍JPBجf‏‰جf‏0جf‏3Lجf‏Twجf‏ھ J َ†`ں¨LUNICEF experienced vaccine shortages and developed strategy to address them:،MMھ M ں¨m VACCINE SECURITY: Ensuring an uninterrupted sustainable supply of affordable vaccines of assured quality ،2mlجf‏ھ n َ‡aںھ ں¨œCONTRACTING OF AFFORDABLE VACCINES Forward commitments Healthy vaccine industry - variety of manufacturers from both industrialized and developing countries،<#z#جf‏y™‏ھ ‌ َى²ں¨;Availability development of the 4 basic vaccines to UNICEF ،$<;3™ے‏ںھ َزœں¨*Foundations to UNICEF Vaccine Procurement ،+i+ھ + َس‌ں¨%UNICEF Vaccine Procurement Principles،&&%ھ & ں êA healthy industry is vital to ensure uninterrupted and sustainable supply of vaccines Procurement from multiple suppliers for each vaccine presentation Procurement from manufacturers in developing countries and industrialized countries Paying a price that is affordable to Governments and Donors and a price that reasonably covers manufacturers minimum requirements UNICEF should provide manufacturers with accurate and long-term forecasts; Manufactures should provide UNICEF with accurate and long-term production plans As a public buyer, providing grants to manufacturers is not the most effective method of obtaining capacity increases The option to quote tiered pricing should be given to manufacturers in accordance with the World Bank classification.،lWں’·WBجf‏T‚جf‏›vجf‏vھ ِ َش‍ں¨%UNICEF Vaccine Procurement Objectives،&&ھ & ں¨@Vaccine Security: Ensure an uninterrupted, sustainable supply of affordable, quality vaccine Compliance to UNICEF Vaccine Procurement Principles Compliance to UNICEF Financial Rules and Regulations Compliance to Public Procurement Principles Integrity Competition Client Service Equal Treatment Organizational Objectives،0ٍ!OٍOھ ] h| َˆbں¨+Additional specific GAVI tender objectives ،,,ں¨A healthy market: ensuring the sustainable quantity of supply through a diverse supplier base Select products and presentations that best meet the need of client countries Achieving a long-term affordable price that countries can eventually finance in a sustainable manner،“" َŒeں¨#GAVI Vaccine procurement Principlesں NIn 2005 the GAVI Board updated the vaccine procurement principles applicable for GAVI. incorporate and expand on the UNICEF s principles Are not conflicting As a procurement agency on GAVI s behalf for a number of vaccines, UNICEF is guided by the GAVI principles for the GAVI funded vaccines.،6XFٹXFٹھ؛hَ²‚ں¨#GAVI Vaccine Procurement Principlesں ھ GAVI recognizes immunization as an important and potentially cost-effective intervention that can enhance the right of all children to a healthy life, that has positive effects in combating poverty and that is a critical contribution to the achievement of public health gains and to the attainment of the Millennium Development Goals (MDGs) for Health. GAVI commits itself to the immediate and long-term aim of vaccine security  the sustained supply of affordable quality vaccines designed to meet the needs of developing countries for sustainable use. GAVI, based on the work of national partners, commits itself to enhancing reliability and predictability in vaccine demand and supply, strengthening the planning and forecasting of vaccine needs in the immunization programs it supports, and ensuring that updated information is readily available to industry - thereby enabling the efficiency of vaccine supply for greatest affordability of vaccines. GAVI recognizes the importance of innovation in the vaccine sector and commits itself to working with industry and national partners to ensure increased use of appropriate under-used vaccines relevant to benefit children most in need, recognizing that success in this will greatly motivate increased research and development of new vaccines including those of relevance to children in developing countries.،VPVھ.O   َ³ƒں¨#GAVI Vaccine Procurement Principlesں¨¾GAVI commits itself to working with national partners and with all industry to ensure increased use of appropriate under-used vaccines to benefit children most in need, recognizing that this in turn will have a positive effect on innovation and development of new products of importance to the developing world. GAVI commits itself to develop effective procurement strategies based upon the type of vaccines, level of maturity and market conditions of the product in question. These strategies will be based on recognition of competition as critical to achieving long-term sustainability, but may also include longer-term contracting arrangements or guaranteeing of minimum volumes with a single supplier. GAVI recognizes the vital role of the vaccine industry in world health improvements and establishes strategies that ensure the participation of both industrialized and developing country manufacturers in providing vaccines for developing countries.،*؟ؤùھ¾ َص¤ںھ ں ‚Establishment of 3 year Supply Arrangements for vaccines included in this tender Current Arrangements cover supply through 2009 Next Arrangements will cover 2010-2012 UNICEF establishes  framework arrangements called Long Term Arrangements (LTA s) Purpose: To establish forecasts between manufacturer and UNICEF on quantities to be produced and quantities to be bought over the time period; Defines Technical, Quality and Commercial requirements ،vQVTئQـ.‰‏VSـ.‰‏ئھ&ô  ة َض ںھ ں¨CUNICEF is fully funded by voluntary contributions Roughly 2/3 Governments and 1/3 Private UN Financial Rules and Regulations UNICEF to fiscal policy to be zero risk UNICEF cannot make external financial commitment without having internal committed commensurate funding Funding and Budgetary Cycles of vaccines Over 500 funding streams for vaccine procurement each year Normally arrives 4-12 weeks prior to delivery Funding changes from year-to-year (one donor is not Government budgets are annual and subject to their release cycles Working on behalf of the poorest countries،ہ2)$’);.،2ـ.‰‏)#ـ.‰‏’)ـ.‰‏; .     ھ D َ×،ں¨LTA Management،ھ  ں °UNICEF issues monthly forecast updates / Manufacturer provides monthly production schedule (12 month period& ) UNICEF places Purchase orders upon receipt of funding for Countries (from 1 week to 6 mo. in advance) UNICEF / Manufacturer hold regular meetings During early 4Q, UNICEF confirms next year s annual forecast projection / Manufacturer confirms production Vaccine is shipped direct to Countries via UNICEF Contracted Freight Forwarder via Manufacturer Vaccine is inspected upon receipt in country Goal is forward funding so that we can place firm commitments with manufacturer s earlier ،œ–P9P.P[PPnجf‏g-جf‏l(جf‏9جf‏.[ھ Y َط¢ں¨Procurement Overview،ھ  َـ©ں¨|The continuous changes in both supply and demand creates a dynamic market that requires continuous monitoring and management،}}ءU‏ھ } ں¨{Systems are in place to monitor demand against supply and to report regularly both to manufacturers, countries and partners،| |3™ے‏ھ | َ‰cں¨+Vaccine Procurement Process and Methodology،,i,ھ , َي³ں¨,The tender process (develop, issue, receipt)ں¨ Development of procurement strategy and objectives Demand / Forecast development Development of draft tender document with PRG* Pre-tender meeting with industry Feedback from industry and finalization of tender document Issuance of tender Clarifications Receipt of proposals (Validity) ،*!“" v£ھ  َî´ں¨)The tender process (evaluation and award)ں¨éTechnical review (by WHO) Quantitative and Qualitative review Clarification meetings with suppliers Evaluation of proposals per Evaluation Criteria & Procurement Objectives Consultation with PRG Recommendation of awards based on evaluation UNICEF internal award approval process GAVI approval, and provision, of any financial requirements Information of outcome to PRG Notification of awards to proposers Public posting of awards (www.unicef.org) Debriefing Establishment of Arrangements ،Ze³" Z…³" ZeI&ھ\Œ        َï¶ںھ ں  October  December 2008: Review and Development Strategy Quantities / Forecast Commercial and Technical Terms and Conditions Feedback and input received from partners December 2008: Pre-tender meeting with manufacturers (10th-11th) Provide programmatic update Present tender process, terms, quantities, to manufacturers Manufacturers provide feedback Adjustments are made as necessary Mid January 2009: Tender Issuance End February 2009: Closing of Tender; target 6 weeks response time March - May, 2009: Evaluation and Negotiation June 2009: Recommendation, issuance of awards July-august 2009: Debriefings January 2010: Deliveries commence ،X0PxPAP›PPx8ـ.‰‏ـ.‰‏ـ.‰‏ـ.‰‏ـ.‰‏›0 %  ھ ‡ َtOں RTender Methodology  Request for Proposal،**ھ * ں¨رRequest for Proposal (RFP) vs. Invitation to Bid (ITB) Tendering for products that are not simple commodities; various factors will be considered in evaluation RFP Provides manufacturers the opportunity to develop a proposal of what is needed for their vaccines to be produced and sold RFP Allows for discussion on different presentation options, production volumes, timing of production for linked and competing vaccines Public opening vs. public posting of awards،&7›7›ھ ز َ!ں¨Tender Duration ،ھ  ں¨XSingle-year vs. Multiple-year Single year: demand is more ad hoc and changing; but not very responsive to manufacture production planning Multi-year: more appropriate for production planning cycles But how long? 2, 3, 5, 10 years Based on feedback from manufacturers Balance between bringing stability to the market and keeping the market active UNICEF opted for 5-year for OPV (2000-2004), but this had varying results Manufacturer had difficult time offering prices over 5-year period Demand changed significantly during that period Current OPV tender 2 year (2009-2010) programme characteristics،¬PھPEPOPJPsP@PھEOJ s  @ ھ&?    َ ں¨ Invitee List، ھ  ں 0Only WHO PQ manufacturers vs. All manufacturers UNICEF buys from WHO PQ manufacturers UNICEF used to only invite WHO PQ manufacturers Optimal duration  procurement agreements for 1yr, 3yr, 5yr? But as we move to multi-year procurement, we don t want to cut out a potential mfr that becomes WHO PQ during multi-year period We also want  new manufacturers to become familiar with UNICEF procurement process ،&0i0iھ ™ َں¨ Product Range،ھ  ں¨fMany vaccines in one tender vs. Separate tender for each vaccine Many products have linkages- in forecast (eg, DTP and combos with DTP; lyopholized products) Vaccine procurement has large number of terms and conditions- lengthy document Lengthy tender process when establishing 3-year arrangements Specific tender objectives and processes for some vaccines ،*A&A&ھ@k     ش َuPں¨Evaluation Criteria Options،ھ  ں¨#Various options to evaluation criteria: Option a) Lowest price is awarded full offered quantity, then second lowest, etc, until required quantity is fulfilled. Option b) Pre-defined weightings of each factor (past on-time delivery performance, price, delivery schedule, future production plans, VVM, shelf-life, ability to maintain buffer stock, timeline for emergency response (packaging), shipping performance, etc.) Option c) Quantitative and Qualitative review (of above factors) against Pre-defined procurement objectives and principles. ،4$'ّھ $ َâھں jWhy not  conditional awards for non-WHO PQ products?،66ھ5 َ"ں¨WWhat happens when manufacturer gets WHO PQ in the middle of a UNICEF multi-year tender?،XXھW َ#ں¨WWhat happens when manufacturer gets WHO PQ in the middle of a UNICEF multi-year tender?،XXھW َ%ں¨When to firm contract?،ھ َ&ں¨When to firm contract?،ھ َ'ں گPost-award Debriefings  What can we know about our competitor s offer? ،2I1ـ.‰‏ھ I ں nAll manufacturers are advised of the outcome of their proposal Manufacturers receiving an award are invited to a formal debriefing Manufacturers not receiving an award may request a debriefing During a debriefing session, the strengths and weakness of the manufacturer s proposal may be discussed. Details concerning the evaluation, results of a competitor will not be discussed, other than to indicate that which is publicly available.،>¸Z@E™ے‏?ô™ے‏ھ ¸ َغ¥ں¨Public Notification of Awards،ں¨زUNICEF has standard procedures for publication of awards on website: Tender, duration, total value, material(s), supplier name This is UNICEF standard procedure (not just immunization) To meet request for information sharing, all Proposers will receive, after awards are made a letter including the following information: Total vaccine quantity awarded per year per presentation at an aggregate level Number of suppliers awarded per year per vaccine presentation Yearly awarded weighted average price (WAP) per vaccine presentation Total contract value awarded to each supplier, with listing of included vaccines. Annual awarded weighted average price for each vaccine presentation will be posted on the UNICEF web-site.،ٹEu‰$lEـ.‰‏sـ.‰‏‰ـ.‰‏$kـ.‰‏ھh< (   L -  vl َ¶ٹں¨#Examples of Controls and Oversight ،$$ں¨j Internal Oversight UNICEF Financial Rules and Regulations UNICEF Procurement Procedures Ethical Code Contracts Review Committee (independent from contracting staff) Procurement Training and Certification of contracting staff External Oversight UN External Audit (French audit in mid-2004 focused on vaccine procurement; no major findings) UNICEF Internal Audit،„ZZخZZuZجf‏خجf‏uَµ‰ں¨,Ensuring equal treatment, no bias and ethics،--ں z Contracting staff are government by Financial Rules and Regulation and procedures related to ethical behaviour During tender period- communication is more formal and written, in accordance with tender instructions Bids/proposals are received and validated by an independent  Bid Section (QA) and then transferred to Contracting staff UNICEF does not accept manufacturers to fund trips, hotels, etc. or gifts Business should be conducted during normal working hours Meetings should be with min. two UNICEF staff members Suppliers not invited to UNICEF staff offices ،|PœPPںPPœں  َف¦ں¨(Tender document and Proposals review: ،,)i%"ھ ) َب–ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨ژSome changes in the structure of the document, but any important content changes will be highlighted in the background section 5 Main Sections: 1- Purpose The objectives of the tender 2- Background Procurement Principles Forecasting Methodologies Programmatic background relevant to understand the requirement Information highlighting changes or specific points such as; scenarios for vaccines, and USD/EURO description 3- Instruction to proposers How to make and submit a proposal Information on how UNICEF will handle proposals, incl definition of mandatory requirements Information on how UNICEF will debrief and share result of tender outcome. ،°‌PPPكPPةPP’ ـ.‰‏ـ.‰‏كـ.‰‏ت  ھ@»   T  s َة—ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨ڑ 4- Terms and Conditions (list not exhaustive) Mandatory technical requirements WHO Technical Requirements Mandatory financial and commercial requirements, such as; UNGM registration Financial Requirements / Approval by UNICEF Supplier Evaluation Unit VVM, Shipping and Packaging Instructions, ETTMD, Vaccine Arrival Report, weight and volumes, samples Commercial Requirements; currency, MFN, Incoterm Account Management, past performance, affordable prices, monthly Allocations, Emergency response preparedness Special terms and conditions; ethical clauses General Terms and Conditions Evaluation of proposals and basis for awards Methodology, process and criteria،x/ZvZWZ}Z"Z/ـ.‰‏vW}"  ھ&‰    َتکں¨%Overview of 2010-2012 Tender Document،&&ھ & ں ‚ 5- Answering sheets RFP Proposal form Qualitative Proposal sheets  for guidance Quantitative Proposal sheets  one for each vaccine, and alternative offered 2010-2012 Tender Quantities Presentation specific Requested information: Quantities, price, currency, commercial factors, lead time, packaging/weight/volume, VVM،@‹¢ـ.‰‏‹¢ھ B َھ}ں¨%Overview of 2010-2012 Tender Document،&&ھ & ں¨¦Annexes UNICEF General Terms and Conditions Shipping Guidelines VVM Specifications WHO Model Inserts UNICEF Supplier Financial Evaluation Form Vaccine Arrival Report ،*ںـ.‰‏ںھ § َwRں¨Proposals from Manufacturers،ھ ں¨VManufacturers are invited to submit a comprehensive proposal Responsive to projected quantities for each product presentation The type of vaccine being proposed, and specifications Unit price per vial and per dose Annual and monthly production for first year Alternative vaccine presentations/products Comply with all MANDATORY REQUIREMENTS Comply with the INSTRUCTIONS TO PROPOSERS and information requested there within Provide explanations to any request for exceptions or clarification on the RFP PROPOSAL FORM UNICEF and WHO will review the proposal and hold discussions with manufacturers ،¢>ZAZ±’" ZxXZذے]ZZQZ<ـ.‰‏j]  Qـ.‰‏ھV َ{Wں¨Proposal Evaluation Process،ھ ں¨×Review of Mandatory Requirements WHO Pre-qualification Financial Review by UNICEF Supplier Evaluation Unit (SEU) Compliance to UNICEF General Terms and Conditions Quantitative Review of Proposal Products offered, quantities, price, delivery schedule, lead-times, ability to maintain buffer stock, shelf life, VVM Qualitative Review of Proposal Proven experience and past performance Ability to perform account management / good communication On-time delivery performance ،€!‚ v€!ـ.‰‏‚ ـ.‰‏vـ.‰‏€ ھ× َ|Xں¨Technical Review of Proposals،ھ ں¨OAll proposals are reviewed by WHO Key areas that WHO review are: compliance to mandatory technical requirements compliance to preferred technical requirements for products not WHO pre-qualified at time of offer, WHO conducted an assessment of timeline given for pre-qualification other technical issues (Regulatory oversight, etc..) ،dC "ـ.‰‏ـ.‰‏ ھO َ}Yں¨Basis for Awards،ھ ں¨àThe allocation of awards to each supplier will be made in accordance with the UNICEF Vaccine Procurement Principles and with the objective of Ensuring an uninterrupted sustainable supply of affordable, quality vaccine. ،nuON'ـ.‰‏ـ.‰‏Nـ.‰‏ھà ًَµں¨ Thank you !،. i "ھ  َم«ں¨:Strategic tender issues pertaining to 2010-2012 tender: ،,;i7"ھ ; َن¬ں¨Overview of 2010-2012 Tenders،ھ  ں¨–3-year Duration: 2010-2012 Request for Proposal Traditional EPI: DTP, TT/DT/Td, HepB, Measles, MMR, MR, BCG HepB/Hib in combination Yellow Fever ،1f—ھ@R     َو®ں¨Middle Income countries (MICs)،ھں Some MIC quantities are included in the EPI tender Countries were UNICEF has a history of procuring on their behalf through VII (Morocco and Philippines) Additional MIC forecasts received for combination vaccines. Currently being assessed Will be identified as MIC/non-GAVI eligible country demand or tendered for separately Feedback from industry on UNICEF s role in supplying MICs is welcome.،`3h<pG3h<pGھ} َç¯ں¨)Country preference and interchangeability،**ھں¨نCountry preference: For vaccines with two pharmaceutical forms available: Vaccines covering the same diseases will be considered as one product for the purpose of the request; however in the tender, we will also indicate the estimated number of doses required for each formulation based on country preferences. Non-Interchangeability: Restricts the short term supply management flexibility, but not the longer term security achieved by a healthy market with multiple suppliers. ،:هـ.‰‏(ـ.‰‏’ھ.$ ”ٌَ·ں¨#Managing transition and uncertaintyں¨xDemand The successful introduction of combination vaccines, needs careful transition management, and is impacting our forecast accuracy The tender aims at transparency on uncertainty by identifying known uncertain quantities due to product change (switchers) Funding When funding availability is a major determinant we share scenarios outlining the different demand profiles ،Püvـ.‰‏‎ـ.‰‏mَé±ں HCurrency of proposals  USD and EURO،%%ں¨Background: UN and UNICEF accounts in USD. With the large value, long durations and multiple transactions associated with vaccine contracts (LTAs) UNICEF has required USD only in the past. EURO contracts require higher degree of internal funds management, planning and coordination with countries to keep up with effect of currency changes. Manufacturers have requested the possibility of quoting in EURO. UNICEF In response to requests: Proposers are required to quote in USD. If they wish Proposers may provide a quote in both USD and EURO. UNICEF will evaluate the USD FCA price or the EURO price, whatever is in the interest of UNICEF, but UNICEF reserves the right to award in USD only. For evaluation purposes the EURO offer will be converted to USD using the UN rate of exchange on the day of the closing of the bid. If a EURO offer is awarded, the resulting LTA will be in EURO throughout its duration. To be an attractive alternative for UNICEF a EURO offer must therefore be lower than the alternative USD offer،نڑP’-P!PMP ـ.‰‏²™B!ـ.‰‏(BWoھvچ  +  -  ء †W pَك¨ں¨Closed vs. public opening،ں¨vSome manufacturers have requested for additional feedback or public opening to have better access to information. Regularly RFP process is without a public opening UNICEF have conducted RFPs with public opening for vaccines as exceptions, but assess that this is not an ideal process for ensuring transparency as the information shared is incomplete and may be misleading.،,wr4ـ.‰‏رھ&¼  · /ًـَ,َ-َ/َ0َ„ َٹَثَجَحَظَà َل!َê"َë#ٍَ$ََ%َô&êّc ï 0`ً ےےے€€€»àم33™™™™ج`ً ےےے–––ûكSے™fج3™f`ً ےےے€€€™جےججے33ج¯gے`ً قٌِ–––ےےےچئےfج¨`ً ےےظwwwےے÷3ججےPPے™`ً €€ےےےZXےے™dbmoاےےے`ً €ےےے\كز“q>9¾y`ےے™س¢`ً ™ےےے3fجےے3fج°fجےےç`ً ےےے3f™مëٌ3™FٹKfجےًه`ً hk]ےےےwwwررثگگ‚€‍¨ےجféـ¹`ً ff™ےےے>>\ےےے`Y{ffے™جےےے™`ً R>&ےےے- كہچŒ{pڈ_/ج´Œ‍ £>ے‎?" dd@ےےïےےےےےے ™ے‏£vے‎?" ddp@ےےïےےےےےے!گ¸ذ@ً`€ £nے‎?" dd@ےےïےےےےےے   @@``€€P£N  ¸ @ ` €`£,p£H¸@`€€£H¸@`€ چً…`ً¨ً#ً( ً ً¨ًà ً¨ “ ً6€`x ‡پƒ؟ہے "ٌ؟ًً0 ًأ   ًTں¨ CLICK TO EDIT MASTER TITLE STYLE¢!ھ !ً% ً¨ ƒ ً0€d‰ پƒ؟ہے "ٌ؟ً°ذpًأ   ًںں¨S Click to Edit Master Text Styles Second level Third level Fourth level Fifth level¢"    ھ Tً‏ ً¨ ƒ ً0€Lf پƒ؟ہے "ٌ؟ًہ€ًأ   ًxں UNICEF * ،  ّھًè ً¨ ƒ ً0€Tض پƒ؟ہے "ٌ؟ً°ذ€ًأ    ًbں *، ْھًà ً¨ ƒ ً0€üB پƒ؟ہے "ٌ؟ً` ذ€ًأ   ًZں *،طھًB ً¨ s ً*پ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ4ٹ,؛___PPT10‹ ê. ؛1_New Brandîƒï €0 ÷ًïpً¬ًچً( ً ً¬ًà ً¬ “ ً6€tt ‡پƒ؟ہے "ٌ؟ً @ہP ًأ   ًTں¨ CLICK TO EDIT MASTER TITLE STYLE¢!ھ !ًف ً¬ ƒ ً0€ہù[ پƒ؟ہے "ٌ؟ًً@ہگ ًأ   ًWں¨#CLICK TO EDIT MASTER SUBTITLE STYLE¢$ھ $ًˆ² ً¬ C ًR€€Aء:Unitepluslogo_Eng_White copy"ٌ؟ً0pہGًB ً¬ s ً*پ™ے“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ4ٹ,؛___PPT10‹ ê.ً ٌ€0 ٹً‚0ً(ًً( ً ً(ًج ً( ƒ ً0€ہ„Dپƒ؟ہے ًP%ًأ  D ًTں *، ùھ ًخ ً( ƒ ً0€شï¸پƒ؟ہے ًگ à%ًأ D ًVں *، ّھ ًd ً( c ً$‡؟ے ?ً·¸(K ًأ Dً ً( ƒ ً0€شî¸پƒ؟ہے ًق @ )ًأ D ً‍ں¨RClick to edit Master text styles Second level Third level Fourth level Fifth level¢!    ھ Sًز ً( “ ً6€بّ¸‡پƒ؟ہے ً»Pàًأ  D ًTں *، ْھ ًش ً( “ ً6€ô÷¸‡پƒ؟ہے ً»گ ààًأ ¸ ًVں *، طھ ًH ً( ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.جïآ Hˆ ة€ ًہً<ً ً( ً ً<ًذ ً< ƒ ً0€p‚¸پƒ؟ہے ًP%ًأ  ¸ ًXں *، ùھًز ً< ƒ ً0€l†¸پƒ؟ہے ًڈ ك%ًأ ¸ ًZں *، ّھًض ً< “ ً6€´‹¸‡پƒ؟ہے ً؛Pكًأ  ¸ ًXں *، ْھًط ً< “ ً6€°!¸‡پƒ؟ہے ً؛ڈ ككًأ ¸ ًZں *، طھًH ً< ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.ثےإگ×9îmï€0 ”ًŒ@ًً$ً( ً‍w ًًr ً S ً€@[ ؟ے¬ًً@ہ ًأ   ً ‍ًr ً S ً€´ح[ ؟ے¬ًP @ہً ًأ [  ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï € 0 وًقًPًvً( ً ًPً¦ ًP  ًF€Œ؛ëپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےً¤جىKًأ    ً ‍ًگ ًP s ً*€4ë؟ے¨ˆًj‍ر* ًأ ë ً‍¦ طش ًH ًP ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًق ًہًvً( ً ًہً¦ ًہ  ًF€ک0 پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےً¤جىًًأ    ً ‍ًگ ًہ s ً*€ Hë؟ے¨ˆًإ‍رvًأ ؟  ً‍¦ طش ًH ًہ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îإï €0 ZًRàًHًêً( ً ًHًx ًH c ً$€°[ ؟ے¨ˆًًًہًأ  [  ً ‍ً¤ ًH c ً$€(چ[ ؟ے¨ˆً ہà ً<$ٌ0أ [  ً ‍ً†2 ًH s ً*…‡پجf؟ہےًPہ p Pً,$ٌD0ًH ًH ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆٹ ؛___PPT10‹ëê.+©°mعDٌ‹'ٌ  ےےےے=ٌ @Bٌ DٌF'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*Hےےےےےےےے%ٌ(ٌَDٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*Hےےےےےےےے%ٌ(ٌَ+8+0+H0 +îشï €0 ûًًًَLً‹ً( ً ًLً¤ ًL c ً$€H ؟ے¨ˆً `ً<$ٌ 0أ   ً ‍ًئ ًL “ ً6€¼ ‡پƒ؟ہے ً`گذ ً`ں¨Elements of Vaccine Security،ھ  ًO ًL ƒ ً0€ط پƒ؟ہے ً°€ہہ ً,$ٌD 0 ً»ں¨ESURE FUTURE FUNDING Donors, Countries Working with Finance Ministries،F2جf‏1™‏ھ F ًXB ًL ƒ ً0…‡؟پ™ے؟ہےًہگ ° °ًآ ًL ƒ ً0€t پƒ؟ہے ً0 °ہ@ً,$ٌD 0 ً.ں¨آACCURATE, LONG-TERM FORECASTING OF DEMAND Improve accuracy and length of forecasting (1-3 year plans at country level) Manufacturers need to give accurate forecasts as well Include buffer stocks،<*™*جf‏ک™‏ھ أ ًXB ًL ƒ ً0…‡؟پ™ے؟ہےً گ ° ًH ًL ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‎ï €0 @ً8ًXًذً( ً ًXًx ًX c ً$€(0 ؟ے¨ˆً`‍´گًأ    ً ‍ً”² ًX م ًTAپƒ†ء؟ہإءے ?¨ˆًذ¯”ث ًأ  ً’2 ًX “ ً6…‡پƒ؟ہءUثںoےًّ] &Iً,$ٌD0ً⢠ًX ƒ ً0€hp ؟پƒ؟ہےًpہگv ً‚ں¨LImplementation of the Vaccine Security principles helps vaccine availability،M 2M3™ے‏ًH ًX ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆeٹ]؛___PPT10‹=ë.ي–اPat´+Uƒ‏‰Dٌ'ٌ  ےےےے=ٌ @Bٌ Dٌج'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ'ٌ =ٌ%ٌ(ٌےےےے%ٌ(ٌDٌ‹'ٌ =ٌ%ٌ(ٌDٌ3'ٌ =ٌ4@BٌگBٌ  Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*Xےےےےےےےے%ٌ(ٌDٌ§'ٌ è=ٌ-ٌo6ٌBٌdissolve*ٌ<3ٌ<ٌû*Xےےےےےےےے+îيï €0 ً 0ًنً¤ً( ً ًنًR ًن s ً*…‡پ™ے؟ہےً€àً~ ًن s ً*€<‹ ‡؟ے¨ˆًj¯´خ ًأ    ً ‍ًB² ًن C ً€€Aءًi€ PًB² ًن C ً€€Aءً¬`ہ4ًH ًن ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îٌ ï €0  ً Pًىً¨ً( ً ًىً¦ ًى  ًF€ô‘ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًïےWwًأ    ً ‍ًآ ًى ƒ ً0€€ک €پجےج؟ے¨ˆًj'قYً<$ٌ0أ   ً‍¦ طش ًH ًى ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îةï €0 ًًè`ًًً€ً( ً ًًً~ ًً s ً*€¼¢ ؟ے¨ˆًI‍¾<ًأ    ً ‍ًآ ًً ƒ ً0€p© €پےے™؟ے¨ˆًگ‍ًًً<$ٌ0أ   ً‍¦ طش ًH ًً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î@ï €0 °ً¨ ًPً@ً( ً ًPًx ًP c ً$€ـ³ ؟ے¨ًً0 ًأ    ً ‍ًˆ ًP S ً€ّ؛ ؟ے¨ً§ـœ«ًأ   ً"‍¦ّ ¨0PpًH ًP ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة`‍bî*ï €0 ڑً’@ ً`ً*ً( ً ً`ًx ً` c ً$€t[ ؟ے¨ًً0 ًأ  [  ً ‍ًr ً` S ً€àt[ ؟ے¨ًzـœ~ًأ [  ً ‍ًH ً` ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة0;Dî@ï €0 °ً¨ ًً@ً( ً ًًx ً c ً$€بآ ؟ے¨ً0Lًأ    ً ‍ًˆ ً S ً€´ث ؟ے¨ًإ'€ًأ   ً"‍¦ّ ¨0PpًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.:Yة°ƒ î^ï €0 خًئ ًً^ً( ً ًًˆ ً S ً€Œk ؟ے¨ًi‍´iًأ   ً"‍¦ّ ¨0Ppً– ً ³ ًB€'؟ ‡پƒ؟ہے ¨ˆً¤پ،Kًأ  ؟  ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.:Yةہ‌îgï €0 ‹ًƒذً ًً( ً ً ً¼ ً  s ً*€شR؛؟ے¨ˆً0PpP ً<$ٌ0أ [  ً‍¦ طش ً ً  س ًN€„,؟ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ًcں¨The Expected Tender Outcome: ،ھ  ًH ً  ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ„ ٹ| ؛___PPT10‹\ ê.+خàEADٌü 'ٌ  ےےےے=ٌ @Bٌ Dٌ· 'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* Q%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* Q€%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* €§%ٌ(ٌَDٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* ¨û%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* ûٹ%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû* ٹء%ٌ(ٌَ+8+0+ 0 +î:ï €0 ±ً©€ًًّAً( ً ًًّ¼ ًّ s ً*€ô؛؟ے¨ˆً0PâP ً<$ٌ0أ ؛ ً‍¦ طش ًE ًّ س ًN€è¾؟ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ً‰ں¨CWhy are they arrangements for what is forecasted and not more firm?،DDھ D ًH ًّ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ1ٹ)؛___PPT10‹ ê.+خàEADٌ©'ٌ  ےےےے=ٌ @Bٌ Dٌd'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌع'ٌ =ٌ%ٌ(ٌےےےےDٌ‚'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ2%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ2[%ٌ(ٌَDٌs'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ\%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ§%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ§%ٌ(ٌَDٌ> 'ٌ =ٌ%ٌ(ٌےےےےDٌو 'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ:%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ:u%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّu£%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ£×%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّ×%ٌ(ٌَDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّD%ٌ(ٌَ+8+0+ّ0 +î؟ ï €0 وًقگًüًvً( ً ًüً¦ ًü  ًF€,3؛پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًwجىًٌأ  ؛ ً ‍ًگ ًü s ً*€Lµ؛؟ے¨ˆًjج‡+ًأ ؛ ً‍¦ طش ًH ًü ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î¤8ï €0 ژً† ً))ًًِ( ً ًً~ ً s ً*€گ­؟ ؟ے¨ˆًwùأًأ  ؟  ً ‍ًï ً ƒ ً0€ô}؛‡؟پ€€€؟ہےً5uœ ًڈں¨3UNICEF Issues Formal Tender and Evaluates Offers ،,43ھ 4 ً’‚ ً م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے1 Tahomaً¼جzˆً8ًz ًbj`P ً ًˆًِ×صـً,$ٌD0ً  ً ƒ ً0€Hر؛‡؟پےے™؟ہےًہj`P ً¤ں¨LEstablishment of Long Term Arrangements for supply of vaccines for 3 years،(MLھ M ًڑ‚ ً م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے2 Tahomaًbؤگً؛ًz ً€`  ً ًˆًچُص‍ ً,$ٌD0ًڑ‚ ً  م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے3 Tahomaً€”.` ًژًN ًٌكً  ً  ًˆًQ` ًئ2 ً  “ ً6€´¢؛…‡؟پےے™؟ہےًٌك»ï  ًXں¨Purchase Order،ھ  ًئ2 ً  “ ً6€Hخ؛…‡؟پےے™؟ہےًpà: ً  ًXں¨Purchase Order،ھ  ًئ2 ً  “ ً6€¼ى؛…‡؟پےے™؟ہےًض à ً  ًXں¨Purchase Order،ھ  ًئ2 ً “ ً6€l ؛…‡؟پےے™؟ہےً6àً  ًXں¨Purchase Order،ھ  ًًz ً’p ê  ً ًˆًc …ف ً,$ٌD0ًڑ‚ ً م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے4 Tahomaً’ؤ @گ ًعًN ً:ذ J  ً ًˆً:p ê ًظز ً “ ً6€ذ؛…‡؟پےج™؟ہےً:ض  J  ًkں¨Manufacturer Shipment،&ھ  ًظز ً “ ً6€¼ل؛…‡؟پےج™؟ہےًْذ ` D  ًkں¨Manufacturer Shipment،&ھ  ًظز ً “ ً6€`Œ؛…‡؟پےج™؟ہےً؛ ذ D  ًkں¨Manufacturer Shipment،&ھ  ًظز ً “ ً6€ط™؛…‡؟پےج™؟ہےًھذ D  ًkں¨Manufacturer Shipment،&ھ  ًعًz ً°@P» ً ًˆًƒ %إ‏ ً,$ٌD0ًڑ‚ ً م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے5 Tahomaً°d^0ً®ًN ًpàë ً ًˆًp@P»ًخٍ ً ƒ ً0€گ؛‡؟پجےج؟ہےًwہ ë ًfں¨Country Inspects،&ھ  ًخٍ ً ƒ ً0€€q؛‡؟پجےج؟ہےً` p ن ًfں¨Country Inspects،&ھ  ًخٍ ً ƒ ً0€àu؛‡؟پجےج؟ہےًہ p€ن ًfں¨Country Inspects،&ھ  ًخٍ ً ƒ ً0€طœ؛‡؟پجےج؟ہےً pàن ًfں¨Country Inspects،&ھ  ًىًz ً€  ً ًˆً†·—ً,$ٌD0ًڑ‚ ً م ًj؟ہہإہےWےےپfج؟ہ™جےثjJے™?؟ے6 Tahomaً€”.` ًہًN ًك¾ً  ً ًˆًs ًس2 ً  “ ً6€س؛…‡؟پجےے؟ہے"ٌ؟`ًك–ï  ًWں¨ Invoice Paid،ھ  ًز2 ً! “ ً6€0§؛…‡؟پجےے؟ہے"ٌ؟`ً¤àّ ً  ًVں¨ Invoice Paid،  ھ  ًس2 ً" “ ً6€è،؛…‡؟پجےے؟ہے"ٌ؟`ًّ à{ً  ًWں¨ Invoice Paid،ھ  ًز2 ً# “ ً6€ّ¯؛…‡؟پجےے؟ہے"ٌ؟`ًjà¾ً  ًVں¨ Invoice Paid،  ھ  ًZٍ ً$ # ًl€xb؛؟G(طےےHîJ³KdذےےL• M(طےےNîپ‚=Jƒ؟ہخے "ٌ؟`ًƒ ءً,$ٌD0 ً|ں¨4If there are disputes on quality, WHO advice governs،55 ھ 5 ًï¢ ً% £ ً<€¤f؛…‡؟پƒ؟ہےً™`”S ً,$ٌ 0 ًOں¨$،'(ـ.‰‏ھ  ًï¢ ً& £ ً<€t؛…‡؟پƒ؟ہےً‚Vٹ<ً,$ٌ 0 ًOں¨$،'(ـ.‰‏ھ  ًqًz ً@ٹ€چ ً' ًˆًٹ@€چً,$ٌD0ًأ¢ ً( £ ً<€کت؛…‡؟پƒ؟ہےً®سâچ ًOں¨$،'(ـ.‰‏ھ  ًٍ ً)  ًf€Tك؛؟GûيےےHع5JïK¶رےےL³(MyظےےN*-پ‚=J؟ہخے "ٌ؟`ً@ٹ€2 ًpں¨Any firm portion requires ،&  ھ  ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?/ً ً$ً)ً ےےے€€€ج™33جججے²²²ˆ¾ٹ¶؛___PPT10‹–+“»‌ٍDٌز'ٌ  ےےےے=ٌ @Bٌ Dٌچ'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌt'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌؤ'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌ)ٌ)ٌ)ٌ)ٌ€?Dٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ےےےےےےےے%ٌ(ٌDٌt'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌؤ'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌ)ٌ)ٌ)ٌ)ٌ€?Dٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ےےےےےےےے%ٌ(ٌDٌt'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌؤ'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌ)ٌ)ٌ)ٌ)ٌ€?Dٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ےےےےےےےے%ٌ(ٌDٌt'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌؤ'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌ)ٌ)ٌ)ٌ)ٌ€?Dٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ےےےےےےےے%ٌ(ٌDٌt'ٌ =ٌ%ٌ(ٌےےےےDٌ'ٌ =ٌ%ٌ(ٌDٌؤ'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌ)ٌ)ٌ)ٌ)ٌ€?Dٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ےےےےےےےے%ٌ(ٌDٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*$ےےےےےےےے%ٌ(ٌDٌ÷'ٌ =ٌ%ٌ(ٌےےےےDٌں'ٌ =ٌ%ٌ(ٌDٌG'ٌ =ٌ4@BٌگBٌ Bٌ °Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*'ےےےےےےےے%ٌ(ٌDٌ»'ٌ ô=ٌ-ٌƒ6ٌBٌ'blinds(horizontal)*ٌ<3ٌ<ٌû*'ےےےےےےےےDٌ'ٌ =ٌ%ٌ(ٌےےےےDٌ¬'ٌ =ٌ%ٌ(ٌDٌT'ٌ =ٌA@BٌگBٌ Bٌ °Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*%ےےےےےےےے%ٌ(ٌDٌ»'ٌ ô=ٌ-ٌƒ6ٌBٌ'blinds(horizontal)*ٌ<3ٌ<ٌû*%ےےےےےےےےDٌ'ٌ =ٌ%ٌ(ٌےےےےDٌ¬'ٌ =ٌ%ٌ(ٌDٌT'ٌ =ٌA@BٌگBٌ Bٌ °Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*&ےےےےےےےے%ٌ(ٌDٌ»'ٌ ô=ٌ-ٌƒ6ٌBٌ'blinds(horizontal)*ٌ<3ٌ<ٌû*&ےےےےےےےے+¨+0+$0 ++0+%0 ++0+&0 +îزï €!0 .ً&0ً$ً¾ ً( ً ً$ً~ ً$ s ً*€h#؛؟ے¨ˆًٍù"ًأ  ؛ ً ‍ًً ً$  ًF€Pû؛پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءآےےےأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًDùZ) ً<$ٌ0أ ؛ ً*‍¦ًّ§ ً$ “ ً6€؛‡پƒ؟ہے ًâ€0 ًAں¨Supply Managementھ ًR ً$ س ًN€„0؛‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nً"¯‎؛ ً–ں¨N~ 40 Vaccines from ~ 16 Suppliers ~ 14 Immunization devices from ~ 8 Suppliers،OOھ O ًX‚ ً$ ƒ ً0…‡پƒ؟ہےً"پ®èً ً$ س ًN€8ھ؛‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًُغ‏چ ًXں¨80-100 countries،ھ  ًƒ¢ ً$ ƒ ً0€ع؟پƒ؟ہےًڑ ù%†ً,$ٌ0 ًïں¨ںUNICEF has the capacity to reallocate demand and supply between Countries and Suppliers, to avert crisis and reduce the impact of demand or supply fluctuations،  ءU‏ھں ًH ً$ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆLٹD؛___PPT10‹$+)9‘÷Dٌک'ٌ  ےےےے=ٌ @Bٌ DٌS'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +DٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*$|%ٌ(ٌDٌA'ٌ =ٌ%ٌ(ٌےےےےDٌé'ٌ =ٌ%ٌ(ٌDٌ‘'ٌ =ٌA@BٌگBٌ Bٌ°Bٌ0Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*$ےےےےےےےے%ٌ(ٌ+p+0+$0 ++0+$0 +îيï €0 ً  ًTً¤ً( ً ًTًR ًT s ً*…‡پ™ے؟ہےً€àً~ ًT s ً*€`ع‡؟ے¨ˆًj¯´خ ًأ  ع ً ‍ًB² ًT C ً€€Aءًi€ PًB² ًT C ً€€Aءً¬`ہ4ًH ًT ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î«ï €$0 آً؛ ً`ًRً( ً ً`ًx ً` c ً$€نع؟ے¨ˆًïے `؟ًأ  ع ً ‍ًگ ً` c ً$€4ع؟ے¨ˆًjجâ ًأ ع ً$‍¦ّ8 0Ppً¢ ً` ƒ ً0€Œع؟پƒ؟ہےً´ج´t ً¢ں¨N*PRG: Procurement Reference Group established for some GAVI supported vaccines،O 2OھN ًH ً` ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië._ںئ@–ڑ³+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î«ï €%0 آً؛@ًhًRً( ً ًhًx ًh c ً$€ب&ع؟ے¨ˆًïے `؟ًأ  ع ً ‍ًگ ًh c ً$€ب/ع؟ے¨ˆًجâf ًأ ع ً$‍¦ّ8 0Ppً¢ ًh ƒ ً0€6ع؟پƒ؟ہےً´ج´t ً¢ں¨N*PRG: Procurement Reference Group established for some GAVI supported vaccines،O 2OھN ًH ًh ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië._ںئ@–ڑ³+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î/ï €0 VًN€ًxًوً( ً ًxًٹ ًx c ً$€بGع؟ے¨ˆً—جüاًأ ع ً‍¦ طش ً ًx س ًN€|ê؟ ‡؟?پƒ؟ ہے?“"ٌ6?@؟`ےہ؟‚‚N؟NےN?Nًً'G— ً`ں¨2010-2012 Tender Timelines،ھ  ًH ًx ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îىï €0  ً گًôً‍ ً( ً ًôً¦ ًô  ًF€xî؟ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  ؟  ً ‍ًگ ًô s ً*€¬ô؟ ؟ے¨ˆًإ‍´… ًأ ؟  ً‍¦ طش ً ًz ًkV ‡¼ ًô ًˆًs k‡ظً,$ٌD0ًh2 ًô s ً*…‡پجf؟ہے"ٌ؟`ًإV P î ً&¢ ًô ƒ ً0€شuع؟پƒ؟ہےًk‡¼ ً¾ں¨VIn general, UNICEF has opted for: Multi-year tenders: RFP Single-year tenders: ITB،8W"جf‏3جf‏ھ W ًH ًô ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ†ٹ~؛___PPT10‹^+k±sْDٌB'ٌ  ےےےے=ٌ @Bٌ Dٌ‎'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ôےےےےےےےے%ٌ(ٌ+îزï €0 ô ًى °ً|ً„ ً( ً ً|ً¦ ً|  ًF€|•عپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًI'Gًأ  ع ً ‍ًٹ ً| c ً$€ج›ع؟ے¨ˆً'€ƒ ًأ ع ً‍¦ طش ً² ً| ƒ ً0€ˆ؟ پƒ؟ہے ًƒ 'gi ًRں،ھ ¦ طش ًRًz ًü} ”½ ً| ًˆًW ‘´—ً,$ٌD0ًh2 ً| s ً*…‡پجf؟ہے"ٌ؟`ًإ} P ًX¢ ً| ƒ ً0€ہ¤ع؟پƒ؟ہےًüC”½ ًًں¨~In general, UNICEF has opted for: 1-year tender: ad hoc needs 3-year tenders: EPI vaccines introduced in routine programmes،("]جf‏ھ&t    ًH ً| ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ†ٹ~؛___PPT10‹^+ˆ ‡DٌB'ٌ  ےےےے=ٌ @Bٌ Dٌ‎'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*|ےےےےےےےے%ٌ(ٌ+îï €0 < ً4  ًxًج ً( ً ًxً¦ ًx  ًF€گ­عپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  ع ً ‍ًگ ًx s ً*€üYع؟ے¨ˆًإ‍Y… ًأ ع ً‍¦ طش ًNًz ً؟گ ‡ِ ًx ًˆًگ ؟‡ًِ,$ٌD0ًh2 ًx s ً*…‡پجf؟ہے"ٌ؟`ًإگ P ( ًT¢ ًx ƒ ً0€ہaع؟پƒ؟ہےً؟V ‡ِ ًىں¨„In general, UNICEF has opted to invite: Multi-year tenders: All manufacturers Single-year or single delivery tenders: WHO PQ mfrs،8…(جf‏[جf‏ھ … ًH ًx ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ†ٹ~؛___PPT10‹^+k±sْDٌB'ٌ  ےےےے=ٌ @Bٌ Dٌ‎'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*xےےےےےےےے%ٌ(ٌ+îvï €0 کًگگًtً(ً( ً ًtً¦ ًt  ًF€àِ پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًIجىًًأ    ً ‍ًگ ًt s ً*€¤s ؟ے¨ˆًâ‍´Cًأ   ً‍¦ طش ًھًz ًkV ‡Q ًt ًˆً`'Z[ً,$ٌD0ًh2 ًt s ً*…‡پجf؟ہے"ٌ؟`ًإV P î ً°¢ ًt ƒ ً0€´‡ ؟پƒ؟ہےًk‡Q ًHں ٹIn general, UNICEF has opted for: Separate tender for OPV: Large volumes, changing demand Separate tender  specials : eg, Rabies, IPV, etc. 01-06 Combined tender: for all vaccines (except OPV, specials) 07-09: Separate tender: EPI Vaccines 07-09: Separate tender: GAVI funded HepB and Hib vaccines 07-09: Separate tender: Yellow Fever 10-12: Separate tender: EPI Vaccines 10-12: Separate tender: GAVI funded HepB/Hib 10-12: Separate tender: YF vaccines،&Pv"جf‏ جf‏جf‏*جf‏ جf‏"جf‏ جf‏ جf‏جf‏ ھtv  ‌    x  % ًH ًt ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ†ٹ~؛___PPT10‹^+k±sْDٌB'ٌ  ےےےے=ٌ @Bٌ Dٌ‎'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*tےےےےےےےے%ٌ(ٌ+îآï €0 ن ًـ  ًًّt ً( ً ًًّ¦ ًّ  ًF€ô¹oپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًI'Gًأ  o ً ‍ًٹ ًّ c ً$€°ؤo؟ے¨ˆً'gƒ ًأ o ً‍¦ طش ً² ًّ ƒ ً0€شخoپƒ؟ہے ًƒ 'gi ًRں،ھ ¦ طش ًBًz ًü} ”م ًّ ًˆً} ü”مً,$ٌD0ًh2 ًّ s ً*…‡پجf؟ہے"ٌ؟`ًإ} P ًH¢ ًّ ƒ ً0€ؤدo؟پƒ؟ہےًüC”م ًàں¨vIn general, UNICEF has opted for: Multi-year tenders: option (c) Single-year or single-delivery tenders: option (a)،:w"جf‏Sجf‏ھ w ًH ًّ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆ†ٹ~؛___PPT10‹^+ˆ ‡DٌB'ٌ  ےےےے=ٌ @Bٌ Dٌ‎'ٌ •ےےےے=ٌ @BٌAٌ?%ٌ,(ٌ <ٌ +O%ٌ,(ٌ <ٌ +Dٌ4'ٌ =ٌ%ٌ(ٌےےےےDٌـ'ٌ =ٌ%ٌ(ٌDٌ„'ٌ =ٌ4@BٌگBٌ Bٌ°Bٌ%ٌ(ٌDٌّ'ٌ =ٌ1ٌ :ٌBٌvisible*ٌo3ٌ>ٌ+Bٌ#style.visibility<ٌû*ّےےےےےےےے%ٌ(ٌ+î±ï €"0 طًذPً,ًhً( ً ً,ًھ ً, s ً*€èْn؟ے¨ˆًMùگ,ًأ o ً8ں ”UNICEF attempted this in 2001-2003 period Experience: We were not good at  picking winner None of conditional award timelines were met (projected time for WHO PQ and production start-up) Several were not met even during the 3-year period Change in approach: We no longer issue conditional awards When a manufacturer product becomes WHO PQ, then award process is initiated (if applicable) Let competitive process determine the  winner (in terms of timing)،r7؛ئ*جf‏ جf‏؛جf‏ئ¦ّ8¨0Ppً~ ً, s ً*€ؤفo؟ے¨ˆًwù¦ًأ  o ً ‍ًH ً, ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î ï €0 8ً0ہً€ًبً( ً ً€ً  ً€ s ً*€ؤü>؟ے¨ˆً`ً‡ًlأ lˆTٹL؛___PPT9‹.¬& ً<ں ô 1. In order to allow for the entrance of new manufacturers in the market UNICEF includes a set of conditions under which award(s) would be considered after the initial award(s). 2. If the supplier was not WHO pre-qualified for the product offered at time of tender, their proposal must have included a detailed plan on the timeline to obtain WHO pre-qualification, including: Product Development Clinical Trials National Regulatory Licensing File submission to WHO 3. If the manufacturer s proposal was deemed of commercial interest to UNICEF, UNICEF and WHO should be kept informed about the progress of the submitted timeline.،ⳓ" ئ]¤ +جf‏j|=جf‏ ]&جf‏aھ,z(ث¦ّ8¨0Ppً~ ً€ s ً*€¤ْl؟ے¨ˆً¤ùشًأ  l ً ‍ًH ً€ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îءï €0 èًààًˆًxً( ً ًˆً؛ ًˆ s ً*€€³D؟ے¨ˆًهً‡ًأ l ًHں¨‚4. If the proposed vaccine obtained WHO pre-qualification and upon confirmation that the mandatory requirements of the RFP are met, UNICEF considers establishing an awarded/re-allocated quantity to the manufacturer under one or more of the following conditions: UNICEF is facing a monopoly situation or a near-monopoly situation; Lack of performance of current manufacturer(s); or Insufficient supply from current manufacturer(s) 5. The quantities considered for award would be those not met under established contracts or quantities that could be reallocated from existing arrangements after negotiation with the corresponding suppliers. ،`ھز„ƒجf‏ھجf‏¬ھ,j(ص¦ّ8¨0Ppً~ ًˆ s ً*€œےl؟ے¨ˆً¤ùشًأ  l ً ‍ًH ًˆ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îEï €0 lًd ًکًüً( ً ًکً> ًک s ً*€èھD؟ے¨ˆً<ùâêًأ > ًجں¨0Context of UNICEF global vaccine supply and funding availability. 95% of funding (non GAVI funding) for over 2 billion doses of vaccines arrives 1-3 months prior to delivery. UNICEF procures for 80-100 countries; each country has 3-7 funding sources UNICEF is cautious to make major changes with industry that will set precedent or expectations that cannot be applied to all vaccines, or may not be sustainable In any case, UNICEF has issued firm contracts; Vaccine in scarce supply and quantity needs to be assured Secure a more favourable commercial offer ،jجdAجf‏جf‏Yجf‏/جf‏e¦ّ8¨0Ppً~ ًک s ً*€ب>؟ے¨ˆًwùًٌأ  > ً ‍ًH ًک ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +îï €0 .ً&@ً ً¾ً( ً ً ً ً  s ً*€,ùD؟ے¨ˆًâجcگًأ D ًژں¨„There are many reasons to firm contract: Avert risk Obtain more favourable commercial conditions Provide assurance to manufacturer(s) And many reasons not to firm contract: Manufacturer not willing to offer reciprocal terms (mfr does not want to accept penalty if production is not available- due to cGMP or batch failure, etc.) May prevent other manufacturer from entering market (either because it is exclusive, or it is perceived as exclusive) Precedent, and unable to sustain, etc. (as mentioned earlier) Therefore, each case needs specific review. UNICEF is dependent on firm funding to firm contract, hence not possible in all markets.،¤)](P‡)جf‏]جf‏'جf‏Pجf‏,جf‏جf‏Yجf‏ھ,v©T¦ّ8¨0Ppً~ ً  s ً*€`ïD؟ے¨ˆًwùًٌأ  D ً ‍ًH ً  ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًق`ً¨ًvً( ً ً¨ً¦ ً¨  ًF€0ِDپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًز¯دLًأ  D ً ‍ًگ ً¨ s ً*€tسD؟ے¨ˆً§¯og ًأ D ً‍¦ طش ًH ً¨ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‰ï €0  ًکàًً0ً( ً ًًx ً c ً$€ہ!D؟ے¨ˆً'G–ًأ  [  ً ‍ًx ً c ً$€ک"D؟ے¨ˆًâù‡ؤًأ D ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î¹ï €0ù^N0 ¸ً°ذ ًDًHً( ً ًDً~ ًD s ً*€@-D؟ے¨ˆًïےùًأ  D ً ‍ًٹ ًD c ً$€¤3D؟ے¨ˆًّہگ,ًأ D ً‍¦ طش ًH ًD ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ‘ّ€€€ج™33جججے²²²ˆ‘ٹ‰؛___PPT10‹ië.âإ“v…+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î¹ï €0ù^N0 ¸ً°ہ ً@ًHً( ً ً@ً~ ً@ s ً*€¤ٍë؟ے¨ˆًïےùًأ  ë ً ‍ًٹ ً@ c ً$€p”D؟ے¨ˆًإہگغًأ ë ً‍¦ طش ًH ً@ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ‘ّ€€€ج™33جججے²²²ˆ‘ٹ‰؛___PPT10‹ië.âإ“v…+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î£ï € 0 تًآًًًZً( ً ًًR ً s ً*…‡پ™ے؟ہےً€àً~ ً s ً*€ vë‡؟ے¨ˆًj¯´خ ًأ  ë ً ‍ًB² ً C ً€€Aءً¬`ہ4ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًقà ًˆًvً( ً ًˆً¦ ًˆ  ًF€\Dپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  D ً ‍ًگ ًˆ s ً*€D؟ے¨ˆًإ‍Y‏ًأ D ً‍¦ طش ًH ًˆ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًقًگًvً( ً ًگً¦ ًگ  ًF€4ئëپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  ë ً ‍ًگ ًگ s ً*€œUD؟ے¨ˆًإ‍Y‏ًأ ë ً‍¦ طش ًH ًگ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًق ًکًvً( ً ًکً¦ ًک  ًF€ہشëپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'G—ًأ  ë ً ‍ًگ ًک s ً*€d~D؟ے¨ˆًإ‍Y‏ًأ ë ً‍¦ طش ًH ًک ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًق° ًüًvً( ً ًüًگ ًü s ً*€‹D؟ے¨ˆً§'=“ ًأ D ً‍¦ طش ً¦ ًü  ًF€œeëپ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےًً'Y—ًأ  ë ً ‍ًH ًü ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‰ï €0  ًکہًً0ً( ً ًًx ً c ً$€„¸؟ے¨ˆًw'Gًٌأ  ¸ ً ‍ًx ً c ً$€¤¸؟ے¨ˆً<T,ًأ ¸ ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‰ï €0  ًک ًً0ً( ً ًًx ً c ً$€ ¸؟ے¨ˆًw'Gًٌأ  ¸ ً ‍ًx ً c ً$€`¸؟ے¨ˆً<Tvًأ ¸ ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‰ï €0  ًک0ًً0ً( ً ًًx ً c ً$€t™¸؟ے¨ˆًw'Gًٌأ  ¸ ً ‍ًx ً c ً$€Lڑ¸؟ے¨ˆً<Tvًأ ¸ ً ‍ًH ً ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î‰ï €0  ًک@ً ً0ً( ً ً ًx ً  c ً$€„§¸؟ے¨ˆًw'Gًٌأ  ¸ ً ‍ًx ً  c ً$€H¨¸؟ے¨ˆً<Tvًأ ¸ ً ‍ًH ً  ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.ےإ° ٹg+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î£ï €&0 تًآ`ًpًZً( ً ًpًR ًp s ً*…‡پ™ے؟ہےً€àً~ ًp s ً*€p’¸‡؟ے¨ˆً¯´ًّأ  ¸ ً ‍ًB² ًp C ً€€Aءً¬`ہ4ًH ًp ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î£ï €#0 تًآ€ً8ًZً( ً ً8ًR ً8 s ً*…‡پ™ے؟ہےً€àً~ ً8 s ً*€بS¸‡؟ے¨ˆًj¯´خ ًأ  ¸ ً ‍ًB² ً8 C ً€€Aءً¬`ہ4ًH ً8 ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î؟ ï €0 وًق ً@ًvً( ً ً@ً¦ ً@  ًF€‎¸پ0e‚ک²ƒ0e„ک²…‡ˆ‰؟  ô   ?€پ‚ƒ„… †ء‡ءˆ‰ٹ‹Œچژڈگ‘’“”•–—ءک™ڑ›œ@؟ ہءأ ؤإءئءابةتث5%جحخدء×ےثثث 8c8c     ?¨A¨)BCD|¾E„|¾…†|¾‡ˆc "ٌےےےےےےےےےےےے ءےےےے?@‍ےےےےںےےےے  ،ء¢ےےےے£ےےےے¤ ¥ء¦ےےےے§ےےےے؟`ظےےےےعےےےےغ ـءفےےےےقےےےےك àءلےےےےâےےےےےہےےےےےےےے آےےےےےےےے آےےےےےےےےڈگ‘’؟‚‚@ABےےےC DEإFإGHIJK5%LMNOإPQRSTUWYےےےےZےےےے[ \إ]ےےےے^ےےےے_ `إaےےےےbےےےےN€پ‚ےےےƒ „…إ†إ‡ˆ‰ٹ‹5%Œچژڈإگ‘’“”•—™ےےےےڑےےےے› œإ‌ےےےے‍ےےےےں  إ،ےےےے¢ےےےے؟Nہءآےےےأ ؤإإئإابةتث5%جحخدإذرزسشص×ظےےےےعےےےےغ ـإفےےےےقےےےےك àإلےےےےâےےےےےNےےے ئئ   5%  ئےےےےےےےے ئےےےےےےےے ئ!ےےےے"ےےےے?N@ABےےےC DEئFئGHIJK5%LMNOئPQRSTUWYےےےےZےےےے[ \ئ]ےےےے^ےےےے_ `ئaےےےےbےےےےً¤ùKًأ  ¸ ً ‍ًگ ً@ s ً*€¸„ ؟ے¨ˆًإ‍Y‏ًأ ¸ ً‍¦ طش ًH ً@ ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€ج™33جججے²²²ˆپٹy؛___PPT10‹Y+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î6ï €0 ¦ً‍ہًHً6ً( ً ًHً~ ًH s ً*€بŒ ؟ے¨ˆًً0 ًأ  [  ً ‍ًx ًH c ً$€ چ ؟ے¨ˆًMپے,ًأ   ً ‍ًH ًH ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.Yة°ڈ¦nî6ï €0 ¦ً‍ذًLً6ً( ً ًLً~ ًL s ً*€H’ ؟ے¨ˆًً0 ًأ  [  ً ‍ًx ًL c ً$€ ™ ؟ے¨ˆًپAًأ   ً ‍ًH ًL ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.6Yةذ‚أ¬îï €0 ًگً|ًھً( ً ً|ًx ً| c ً$€ب¨ ؟ے¨ˆً¯oî ًأ   ً ‍ًٍ ً| s ًٹ€ © پ0e‚ک²ƒ0e„ک²…†‡ˆ‰ٹ‹؟پƒ؟ہے ¨ˆ#"ٌ Œچ0eًً0 ًأ    ً ‍ًH ً| ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ‘ٹ‰؛___PPT10‹ië.8Yةpg@+Dٌ='ٌ  ےےےے=ٌ @Bٌ +î0ï €0  ًکًًTً0ً( ً ًTًx ًT c ً$€,¸ ؟ے¨ˆً•'G<ًأ    ً ‍ًx ًT c ً$€ش¸ ؟ے¨ˆً½ùY†ًأ   ً ‍ًH ًT ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.-Yةً{™]î6ï €0 ¦ً‍ ً ً6ً( ً ً ً~ ً  s ً*€إ ؟ے¨ˆًً0 ًأ    ً ‍ًx ً  c ً$€, ؟ے¨ˆًMTQًأ   ً ‍ًH ً  ƒ ً0پƒ“ژں‹”ق½h؟ے ?ً ےےے€€€»àم33™™™™جˆ8ٹ0؛___PPT10‹ë.-Yةذ¥ءSًèٌ0 ¨ً ذً„ً8ً( ً ً„ًd ً„ c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ً„ s ً*€<خ¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ً„ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ًèٌ0 ¨ً ًًŒً8ً( ً ًŒًd ًŒ c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ًŒ s ً*€طس¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ًŒ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ًèٌ0 ¨ً 0ًœً8ً( ً ًœًd ًœ c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ًœ s ً*€tظ¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ًœ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ًèٌ0 ¨ً Pً¤ً8ً( ً ً¤ًd ً¤ c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ً¤ s ً*€ك¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ً¤ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ًٌ 0 ˆً€°ً<ًً( ً ً<ًX ً< C ً؟ے(ً·¸(K ًأ  ¸ً€ ً< S ً€t,¸؟ے(ًق @ )ًأ  ¸ ًں ذWe will take all feedback into considerations, but not necessarily accommodate all industry s request. Focus is to ensure Vaccine Security, not cater to industry s every desiree. Feedback post awards; including debriefing sessions ھ.ھ4 ًH ً< ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ùXة@+Lîً(ٌc0 ¨ً  ًXً8ً( ً ًXًd ًX c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ًX s ً*€$I¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ًX ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ًµٌ–0 5ً-ً ًŒًإً( ً ًŒً^ ًŒ S ً؟ے(ˆً·¸(K ًأ  ¸ً' ًŒ c ً$€pê¸؟ے(ˆًق @ )ًأ  ¸ ً»ں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ,  QًH ًŒ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ًµٌ—0 5ً-ً”ًإً( ً ً”ً^ ً” S ً؟ے(ˆً·¸(K ًأ  ¸ً' ً” c ً$€g¸؟ے(ˆًق @ )ًأ  ¸ ً»ں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ,  QًH ً” ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ًµٌک0 5ً-0ًœًإً( ً ًœً^ ًœ S ً؟ے(ˆً·¸(K ًأ  ¸ً' ًœ c ً$€|¸؟ے(ˆًق @ )ًأ  ¸ ً»ں¨sInstruction to proposers: Incoterms, errors, validity, registration, country of origin, samples, debriefings etc. ھ,  QًH ًœ ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yةًûھ‍ً(ٌœ0 ¨ً @ًèً8ً( ً ًèًd ًè c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ًè s ً*€ً5¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ًè ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ً(ٌ¦0 ¨ً ًً8ً( ً ًًd ً c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ً s ً*€¬ن¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ً ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ً@ٌ©0 ہً¸@ً(ًPً( ً ً(ًd ً( c ً$؟ے(ˆًآء:] ًأ  ¸ً¬ ً( s ً*€¸<¸؟ے(ˆًم P¨?ًأ  ¸ ً:ں،Zھ ًH ً( ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ں%ئ أ¶ًèٌھ0 ¨ً `ً0ً8ً( ً ً0ًd ً0 c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ً0 s ً*€ ب¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ً0 ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ً(ٌ«0 ¨ً گً<ً8ً( ً ً<ًd ً< c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ً< s ً*€¸Z¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ً< ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—ًٌ³0 کًگ0ًdً(ً( ً ًdً^ ًd S ً؟ے(ˆً·¸(K ًأ  ¸ًٹ ًd c ً$€¨‡¸؟ے(ˆًق @ )ًأ  ¸ ًںھ ًH ًd ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yة0‏vًٌ´0 کًگPًlً(ً( ً ًlً^ ًl S ً؟ے(ˆً·¸(K ًأ  ¸ًٹ ًl c ً$€أ¸؟ے(ˆًق @ )ًأ  ¸ ًںھ ًH ًl ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.Yة0‏vً(ٌµ0 ¨ً pًtً8ً( ً ًtًd ًt c ً$؟ے(ˆً·¸(K ًأ  ¸ً” ًt s ً*€8d¸؟ے(ˆًق @ )ًأ  ¸ ً"ںھ ًH ًt ƒ ً0پƒ“ق½h”قٍچ؟ے ?ً ےےے€€€ج™33جججے²²²ˆ8ٹ0؛___PPT10‹ë.ِ0أPg8—rگ^ة ؤ¾سثvت @T»z«wôگ‎%0Y¦µ, ´o¤q/ ”s„uMضؤt †œôفwVJ{0çLxO R„tw†Paك.èخôژ„{Œ ھڈ@² H گ µ خ ب€:#-ب6´}q€.ƒخ°9»رگڑص÷ْ‎ِe§7nAë…غ0|zڈ ك`vmˆKٹ¾يEWًYو ·cُeéہ>k“Œƒژ ï鑜•O™ڑT3h³گس’َ”ُ®#—ôإ1‏ےà…ںٍùOh«‘+'³ظ0ؤT hp” ¬ ¼ب è ô  نCLICK AND TYPE TITLE HERErdmkdorgan88Microsoft PowerPoint@ذجë²ز@€Hô‏إ@P!oغg\ةéG¨Sےےےے‰g  ج)،'  رء ÷€€€€€€€€€ہہہہـہ¦تً """)))UUUMMMBBB999ے|€ےPPض“جىےïضئççض­©گ3f™ج333f3™3ج3ے3f3fff™fجfےf™3™f™™™ج™ے™ج3جfج™جججےجfے™ےجے333f3™3ج3ے333333f33™33ج33ے33f33f3ff3™f3جf3ےf3™33™3f™3™™3ج™3ے™3ج33ج3fج3™ج3جج3ےج33ے3fے3™ے3جے3ےے3f3fff™fجfےf3f33ff3f™3fج3fے3fff3fffff™ffجff™f3™ff™f™™fج™fے™fجf3جf™جfججfےجfےf3ےf™ےfجےfےججے™™™3™™™ج™™33™f™ج3™ے™f™3f™f3™™f™جf™ے3™3™™f™™™™™ج™™ے™™ج™3ج™fجf™ج™جج™ےج™ے™3ے™fج™™ے™جے™ےے™ج3™fج™ججج3™33جf3ج™3جج3جے3جfج3fجff™™fججfجےf™™ج3™جf™ج™™جج™جے™ججج3ججfجج™جججججےججےج3ےجfے™™ےججےجےےج3جfے™ے3ج33ےf3ے™3ےج3ےے3ےfے3fےffج™fےجfےےfج™ے3™ےf™ے™™ےج™ےے™ےجے3جےfجے™جےججےےجے3ےےfےج™ےےجےےےfffےfےےfffےےfےfےے¥!___www†††–––ثثث²²²×××فففمممêêêٌٌٌّّّےûً  ¤€€€ےےےےےےےےےے4،'A جx ذہ( xK€€€€€€€€€ہہہہـہًت¦ """)))UUUMMMBBB999€|ےPPے“ضےىجئضïضççگ©­3f™ج3333f3™3ج3ےff3fff™fجfے™™3™f™™™ج™ےجج3جfج™جججےےfے™ےج3333f3™3ج3ے3333333f33™33ج33ے3f3f33ff3f™3fج3fے3™3™33™f3™™3™ج3™ے3ج3ج33جf3ج™3جج3جے3ے33ےf3ے™3ےج3ےےff3fff™fجfےf3f33f3ff3™f3جf3ےffff3fffff™ffجf™f™3f™ff™™f™جf™ےfجfج3fج™fججfجےfےfے3fے™fےججےےج™™™3™™™™ج™™33™f™3ج™ے™f™f3™3f™f™™fج™3ے™™3™™f™™™™™ج™™ے™ج™ج3fجf™ج™™جج™جے™ے™ے3™جf™ے™™ےج™ےےج™3جfج™جج™3ج33ج3fج3™ج3جج3ےجfجf3™ffجf™جfج™fےج™ج™3ج™fج™™ج™جج™ےجججج3ججfجج™جججججےجےجے3™ےfجے™جےججےےج3ےfے™ج3ے33ے3fے3™ے3جے3ےےfےf3جffےf™ےfججfےے™ے™3ے™fے™™ے™جے™ےےجےج3ےجfےج™ےججےجےےے3جےfےے™ےےجffےfےffےےےffےfےےےf!¥___www†††–––ثثث²²²×××فففمممêêêًٌٌٌّّّûے¤  €€€ےےےےےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشسسسسسشسسسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشعسسسسسسسشسسششسسشعسسسسسسسعشعسسسسسسسسسسسسسسسسسسسسسسسسسسـشغشـغـعـشغغـشغسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشâغâغلشسـغـعـــعـــغشلسسشلــغâغسسسسسسسسسسسسسسسسسسسسسسسسغغصغغـغغــصـغغشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـصســـعسـصفغـسعغâسششغـسســــےصـشسسسسسسسسسسسسسسسسسسسسسسسعشغشعغعشغسشسعشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـغسـغلشسـغـلغسسغâــâعلسعـâـغââـلسسسسسسسسسسسسسسسسسسسسسسسسشسسسشسششسسسسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسـغسغـــسâشâشـسـشفشغـغـششـâـشےےــسسسسسسسسسسسسسسسسسسسسسسسـغلشغغغغغسغغغغغسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسشغسغشغغلغعغسغلغسشلـعـâشعغلےــâغـسسسسسسسسسسسسسسسسسسسسسسسغغغغغغغغغششغصغغشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسغسسسسسسسسسعـسسغشےغغشعشسسسسسسسسسسسسسسسسسسسسسسسعسسسعععسعسغغعسشسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسعـعسسسسسسسسسلـعسسشلـعسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےےےےےسےےےےےسےےےےےےےےسےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےےےےےےےسےےےےسےےےسےےےےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسےےسسےسسسےےسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسسسسسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےےےےےےےےسےسےےےےےےےسسسسسسےےسسےےسےےےےےےےسےےےےےسےسےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےےےےےےےےےےےےےےےےےےسےسےسےےےسےسےےےےےےےےےےےےےےسسےےےےےسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسسسسسسسےسسسسسسسسسسسسسسےےسسےےسسسسسسسسسےسسسسسےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےسےےےےےسسےسسےےسےےےےےےےسسےےےسسےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےےےےےےسےےسےےسسےسےےےےےےےےسےسےےےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسےےسےےےےےسسےسسےےسسسسسسےسسسےےےسسےسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےےےسسسےےےسےےےےےسےےسےےےےےےےسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسےےےسےسےےےےےےےےےسےےےےےےےےےےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےسسسسسےسسسسسسسسسسسےسےسسسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسےےےسےسسےسسےےےسسےےےسےسسسسسسےسسسسےسسسےےسسسےےسسسےےےےےےسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےسسسسےسسےسےسسےسےسسسسےسسسسسسےسسسسےسسےسسےسےسسےسےسسسسسسےسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےےےےسےسسےسےسسےسےےےےسےسسسسسسےسسسسےسسےسسےسےسسسسےےےےسےےسسسےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےسسےسےسسےسےسسےسےسسےسےسسسسسسےےےےسےسسےسسےسےسسےسےسسےےسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسےےسسےےےسسسےےےسسےےسسےےےسسسسےسسےسےےےسےےسسسےےسسسےےسسےےےسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسسسسسسسسسسسسےسسسسسسسسسسسسسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےےےسسسسسسسسسسسسسےسسسسسسسسسسسسسےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسسسےےسسسےےسسسےےےسےسسسےےےسےسسےسسےسےےےسےسسےسےےسسسسسےےےسسسےسسسسےےےسےسسسےسسےسسےےےسسےسےسسسسسےےےےسےسسےسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسسےسسےسےسسےسےسسےسےسسےسسسسےسسےسسےےسسسسےسسےسےسسسسسےسسسےسےسےسسےسسسسےسسےسےسےسےسسسسےسےسےسسسسےسسےسےسسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسےسسےسسےسےسسسسےسسےسےسسےےےےسےسسےسسےےےےےسےسسےسےسسسسسےسسسےسےسےسسےےےےسےسسےسےسےسےےےےسےسےسےسسسسسےےےسےسسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےےسےسسےسسےسےسسےسےسسےسےسسےسسےسےسسےسسےےسسےسےسسےسےسسسسسےسسسےسےسےسسےسسےسےسسےسےسےسےسسےسےسےسےسسسسسسسےسےسسےسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےسےےےسےےسسسےےسسےسسےسےےےسےےسسےےےےےےسسےےسسےےےسےےےسسسسےسسسےےسسسےسسےےسسےےےسسسےےسسےےسسےسےسےسسسسےےےےسےےےسسسےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسسےسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسےےےسسسسسسسسسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسےسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسسس‏ےصحصœ.“—+,ù®0` ˆگ¨¸ہبذ ط àè ًّ  ‏ نOn-screen ShowUnicef[5« =TimesArialTimes New Roman Arial BlackSymbolTahoma Courier New 1_New Brand(Procurement Overview and Tender ProcessConsultations with Industry FindingsMUNICEF experienced vaccine shortages and developed strategy to address them:Slide 5<Availability development of the 4 basic vaccines to UNICEF +Foundations to UNICEF Vaccine Procurement &UNICEF Vaccine Procurement Principles&UNICEF Vaccine Procurement Objectives,Additional specific GAVI tender objectives $GAVI Vaccine procurement Principles$GAVI Vaccine Procurement Principles$GAVI Vaccine Procurement Principles Slide 14 Slide 15LTA ManagementProcurement Overview}The continuous changes in both supply and demand creates a dynamic market that requires continuous monitoring and management,Vaccine Procurement Process and Methodology-The tender process (develop, issue, receipt)*The tender process (evaluation and award) Slide 22*Tender Methodology – Request for ProposalTender Duration Invitee ListProduct RangeEvaluation Criteria Options6Why not ‘conditional awards’ for non-WHO PQ products?XWhat happens when manufacturer gets WHO PQ in the middle of a UNICEF multi-year tender?XWhat happens when manufacturer gets WHO PQ in the middle of a UNICEF multi-year tender?When to firm contract?When to firm contract?IPost-award Debriefings “What can we know about our competitor’s offer?”Public Notification of Awards$Examples of Controls and Oversight -Ensuring equal treatment, no bias and ethics)Tender document and Proposals review: &Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender Document&Overview of 2010-2012 Tender DocumentProposals from ManufacturersProposal Evaluation ProcessTechnical Review of ProposalsBasis for Awards Thank you !;Strategic tender issues pertaining to 2010-2012 tender: Overview of 2010-2012 TendersMiddle Income countries (MICs)*Country preference and interchangeability$Managing transition and uncertainty%Currency of proposals – USD and EUROClosed vs. public opening  Fonts UsedDesign Template Slide Titles5Root Entryےےےےےےےےچپd›Oد†êھ¹)èگâ6#ثؤ@Picturesےےےےےےےے|پCurrent Userےےےےےےےےےےےے;SummaryInformation(ےےےےژôTپ‚ƒ„…†‡ˆ‰ٹ‹Œچ‏ےےےڈگ‘’“”•–—ک™ڑ›œ‌‍ں ،¢£¤¥¦§¨©ھ«¬­®¯°±²³´µ¶·¸‏ےےے؛»¼½¾؟ہ‏ےےےخ‎ےےے‏ےےے‏ےےےےےےےےےےےےےےےےےےے‎ےےے‎ےےے‎ےےےےےےےےےےے‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےے‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےِ!_ہ‘م»ک ôrmatthewsrmatthewsRoot Entryےےےےےےےےچپd›Oد†êھ¹)èà„وھbHثب@Picturesےےےےےےےے|پCurrent Userےےےےےےےےےےےے2SummaryInformation(ےےےےژôTپ‚ƒ„…†‡ˆ‰ٹ‹Œچ‏ےےےڈگ‘’“”•–—ک™ڑ›œ‌‍ں ،¢£¤¥¦§¨©ھ«¬­®¯°±²³´µ¶·¸‏ےےے؛»¼½¾؟ہ‏ےےےےےےےےےےےےےےےےےےےخ‎ےےے‏ےےے‏ےےے‎ےےے‎ےےے‎ےےےےےےےےےےے‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےے‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےِ_ہ‘م»کôUNICEFUNICEFhews  !"#$%&'()*+,-./0123456789:;<=>?@‏ےےےBCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~€پ‚ƒ„…†‡ˆ‰ٹ‹Œچژڈگ‘’“”•–—ک™ڑ›œ‌‍ں ،¢£¤¥¦§¨©ھ«¬­®¯°±²³´µ¶·¸¹؛»¼½¾؟ہءآأؤإئابةتثجحخدذرزسشصض×طظعغـفقكàلâمنهوçèéêëىيîïًٌٍَôُِ÷ّùْûü‎‏ے      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~€پ‚ƒ„…†‡ˆ‰ٹ‹Œچ‏ےےےڈگ‘’“”•–—ک™ڑ›œ‌‍ں ،¢£¤¥¦§¨©ھ«¬­®¯°±²³´µ¶·¸‏ےےے؛»¼½¾؟ہ‏ےےےآأؤإئاب‏ےےے‎ےےے‎ےےے‎ےےے‎ےےےخ‏ےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےےRoot Entryےےےےےےےےچپd›Oد†êھ¹)è‏ےےےPicturesےےےےےےےےےےےے|پCurrent UserےےےےےےےےءSummaryInformation(ےےےےژôTPowerPoint Document(ےےےےےےےےےےےےAكکDocumentSummaryInformation8ےےےےےےےے¹ےےےےےےےےےےےےےےےےےےےےےےےے